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ABSTRACT 
Significance/Background: Obstructive Sleep Apnea (OSA) is the most common 
disturbance during sleep affecting 30% of the population. The occurrence of 
moderate/severe OSA is 11.4% in men and 4.7% in women. OSA is caused by repetitive 
partial or complete obstruction of the upper airway with apnea episodes. OSA is 
prevalent in western society, yet is frequently undiagnosed due to lack of knowledge of 
the disorder. This population presents a challenge during the peri-operative period due to 
increased risk for several complications. Of particular interest to Nurse Anesthetists, are 
respiratory complications that result in delayed emergence from anesthesia, delayed post­
operative recovery, increased apneic episodes, hypoxemia, and death. Examining 
duration of recovery periods between the two OSA groups will help determine if patients 
with additional cofactors benefit from longer post-operative monitoring or modification 
of anesthetic technique. 
Methods: An observational correlation design to include a non-randomized convenience 
sample of two groups. Comparisons were made between groups regarding cofactors, 
complications and duration of postoperative recovery times. Patients having elective 
abdominal surgery under general anesthesia were identified. OSA status was determined 
based upon Sleep Studies, or STOP-BANG tool criteria. Medical, surgical, and 
anesthesia data was reviewed. Total recovery times and pre-existing disease documented. 
Multiple Logistic and Regression testing compared effects of cofactors on postoperative 
recovery times. Chi square analysis evaluated relationship of individual cofactors with 
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OSA and Non-OS A patients. T-test analysis compared demographic information. P score 
of < .05 was considered significant. 
Results: This study indicated significant correlation with higher number of cofactors 
amongst patients diagnosed with OSA (p< 0.012). Increased incidence of higher ASA 
classification in OSA diagnosed patients; (p< .017) extended PACU stay time in OSA 
diagnosed patients; (p= 0.05) and unplanned admissions in OSA patients; (p=. 007). 
Patients with OSA use higher number of prescribed medications compared to non-OSA 
patients have a 3.36 greater chance of hypertension as an additional cofactor (p< .05) and 
were 8.75 times more likely to experience airway difficulties or complications with 
general anesthesia when compared to non-OSA patients (p< .05). Multiple logistic 
regression testing demonstrated increased incidence for both airway difficulties (p= .003) 
and Hypertension (p=. 054). Multiple linear regression results indicate one cofactor HTN 
as a significant predictor for PACU stay time. (R2= .179, R2adj = .136, F (1)) 
Implications: Findings will lead to optimum monitoring, management; recovery measures 
and anesthesia techniques that will prevent extended postoperative periods and reduce or 
eliminate postoperative complications of OSA. 
Key Words: Obstructive Sleep Apnea, Cofactors, STOP-BANG 
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CHAPTER 1 
Introduction 
Obstructive Sleep Apnea (OSA) is the most common disturbance during sleep 
affecting 2-26% of the general population. (Chung et al, 2008) The occurrence of 
moderate to severe OSA is estimated to be 11.4% in men and 4.7% in women. (Seet et al, 
2010) OSA is a prevalent problem in Western Society estimated to occur between 1 to 
9% in patients presenting for surgery, yet it is frequently undiagnosed due to lack of 
awareness or knowledge of the disorder. (Kaw et al, 2006) 
OSA is caused by repetitive partial or complete obstruction of the airway during 
sleep. Diagnosis of OSA is determined by the occurrence of airway obstruction during 
sleep with apnea periods lasting greater than 10 seconds for five or more times per hour 
with a resultant decrease in arterial oxygen saturation (Sa02). (Seet et al, 2010) These 
events are known as apnea/hypopnea episodes and the measurement of episodes is 
referred to as the Apnea-Hypopnea Index [AHI]. The degree of severity of this disorder is 
determined by the number of AHI's per hour (AHI: 5-15 mild, > 15-30 moderate, and > 
30 severe). 
A Polysomnography study otherwise known as a Sleep Study is recognized as the 
"Gold Standard" for the diagnosis of OSA. Polysomnography data defines the degree of 
severity of the condition by the number of apneic episodes. Unfortunately 
polysomnography testing is time consuming; patients are reluctant to participate in them, 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 6 
they require an extended stay in the sleep lab; and are expensive. Medical professionals 
have become more aware of OSA as a significant disorder with resulting adverse effects 
for their patients. More physicians are consulting to polysomnography specialists for 
sleep studies to ascertain occurrence and severity of OSA, and the availability of 
appointments have become more limited. Unfortunately for the OSA patient scheduled 
for surgery, polysomnography cannot be obtained rapidly and this may be the cause of 
OSA going undetected. (Chung, 2008) Subsequently, the OSA patient population 
presents a unique challenge during the peri-operative period due to an increased risk for 
lack of identification and subsequent life threatening complications. Of particular interest 
to the Nurse Anesthetist treating a OSA patient, are the respiratory complications that can 
result in delayed emergence from anesthesia, delayed post operative recovery, increased 
apneic episodes, hypoxemia, cardiac disturbances, and ultimate death. 
Obesity, gender, snoring, and age are strong indicators in the occurrence for OSA. 
Hypertension, cardiovascular disease, diabetes, and stroke are prevalently reported as 
confounding and coexisting factors. (Dykes et al, 1996) Netzer at al. (2003) surveyed 
OSA patients in 26 US primary care clinics and 14 European primary care clinics. 
Comparison of the results indicated similar symptoms regardless of age, gender, and 
hypertension. Obesity was common between both sets of OSA patients although the 
incidence was much higher in the United States than in Europe. In a Spanish study, 
Duran et al. (2001) reported linkages between OSA and hypertension after interviewing 
over 2,000 patients. 
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The predominant cardiovascular effects of OSA are hypertension and refractory 
bradycardia followed by abrupt tachycardia. (Vanninen et al, 1996). The hemodynamic 
instability seems to be related initially to hypoxemia from the airway obstruction, and 
then sudden arousal as the patient awakens to breath. The rapid fluctuations of vaso-
activity is thought to be responsible for the incidence of cardiac arrhythmias, the 
development of chronic arterial hypertension, the occurrence of myocardial infarction, 
and sudden cardiac death (Vanninen et al, 1996) 
The severity and incidence of documented post surgical complications from patients 
with moderate to severe OSA is significant. Yet, most of the data on incidence, 
occurrence, surgical complications and treatment of the OSA patients come from case 
reports and retrospective reviews not empirical studies. (Chung et al, 2008) 
The American Society of Anesthesiologist (ASA) developed guidelines in 2006, 
based on Level IV evidence and expert consensus reports to address the identification and 
treatment needs of the OSA patient. The ASA consultants reached agreement on 
treatment criteria for most simple outpatient and minor orthopedic surgical procedures 
but could not find consensus regarding more invasive surgeries. The guidelines 
emphasized that certain factors needed to be considered when determining both 
preoperative and postoperative risk for the OSA patient: status of sleep apnea, (treated or 
untreated), level of comorbidities (hypertension, cardiovascular disorders, diabetes are 
they appropriately managed), type of surgery, and anesthesia modality. 
(Chung et al, 2008) The key experts in the diagnosis and treatment of the OSA patients 
acknowledge the poor quality of evidence. A citation from the American Academy of 
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Sleep Medicine stated that the scientific literature regarding perioperative risk and best 
management techniques for OSA patients was scanty and of limited quantity, more 
empirical studies are needed. (Meoli et al, 2003). The ultimate goal for all Nurse 
Anesthetists is to provide the safest, highest quality anesthetic management and care to 
their patients. If Nurse Anesthetists can identify and understand the coexisting factors 
creating the greatest risk for perioperative complications in the OSA patient, they can 
better prepare themselves to manage those risks and provide optimum care. Nurse 
Anesthetists can select anesthetic practices that minimize risk and maximize safer 
outcomes. Development of more concise and accurate techniques to eliminate the factors 
producing increased risk for this population could be incorporated. Valid criteria for 
preoperative identification of the OSA patient could be developed and preoperative 
management techniques could be identified. Established guidelines and protocols could 
be created to decrease or eliminate most if not all risk factors. The complete elimination 
of incidence and occurrence of morbidity and mortality for the OSA patient in the 
perioperative environment would be the ultimate goal. 
Purpose and Specific Aims 
The purpose of this study is to identify preexisting factors that significantly impact 
postoperative recovery times for patients undergoing surgical procedures. 
Specific aims of this study include: 
Aim 1. To examine the difference between the postoperative stay times of OSA and 
Non- OSA patients. 
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Aim 2. Compare OSA and Non OSA patients in regards to existing cofactors and 
medical treatments 
Aim 3. Assess the relationship between OSA and airway management difficulties and 
complications 
Aim 4. Assess the relationship between the pre-existing cofactors of: Hypertension, 
Cardiovascular disease, diabetes and GERD. 
Aim 5. Examine which of the pre-existing cofactors account for the explained 
variance in postoperative recovery time. 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 10 
CHAPTER TWO 
Literature Review 
The purpose of this study is to identify preexisting factors that significantly impact 
postoperative recovery times for Obstructive Sleep Apneic patients undergoing surgical 
procedures. Obstructive sleep apnea (OSA) both diagnosed and undiagnosed is one pre­
existing factor identified as increasing medical and surgical risks and ultimately increased 
morbidity and mortality for individuals during the surgical, and perioperative 
environment. Yagg and associates (2005) argue untreated OSA significantly and 
independently increased the incidence of stroke or death from any other underlying 
cause. Patients with undiagnosed OSA pose greater risk of airway compromise and 
require additional measures and management regimes to ensure safe anesthesia care and 
decreased PACU length of stay, information related to the existence of co-morbidities is 
of great significance. The effects of OSA and coexisting disease in the perioperative 
setting have not been fully explained. Does OSA have a significant impact on underlying 
disease processes that lead to perioperative complications and increased length of PACU 
stay? A review of the relevant literature was conducted to identify the current state of the 
science on the effects of OSA and coexisting factors on perioperative care. In this chapter 
the literature review is presented to include OSA, OSA and comorbidities, assessment of 
OSA, and the impact on health outcomes. The theoretical framework " Startling Resistor 
Theory" guiding the study will also be presented. 
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Obstructive Sleep Apnea 
Obstructive sleep apnea (OSA) is a disorder becoming much more prevalent within the 
population of the United States and Europe. Obstructive sleep apnea is a disorder that 
occurs during the normal sleep cycle of certain individuals and can be elicited during 
surgery or medical procedures using sedation and general anesthesia. Obstructive sleep 
apnea is caused by repetitive partial and complete obstruction of the upper airway by 
relaxed pharyngeal muscle and tissues during normal sleep. It is also facilitated by 
implementation of vaporized anesthetic agents during surgery and the introduction of 
narcotics and analgesic medications for deep sedation (Chung et al, 2008). 
The etiology of OSA is not completely understood but there is a general consensus that 
the negative pressure created by the inspiratory muscles exceeds the capacity of the upper 
airway dilator muscles to maintain airway patency, thus obstruction of the nasopharynx, 
oropharynx, and laryngopharynx are obstructed (Chung et al, 2008). The tensor 
palantine, genioglossus, and hyoid muscles contract to dilate and elevate the 
nasopharynx, oropharynx, and laryngopharynx respectively. Action of the tensor palatine 
is mainly tonic activity and this action decreases during sleep leading to upper airway 
resistance. The action of the genioglossus is phasic with inspiration; contraction of this 
muscle advances the tongue forward and is essential in keeping the tongue from blocking 
the oropharynx. Genioglossus function also decreases with sleep and has been shown to 
cease completely during rapid eye movement (REM) sleep. Studies have noted that OSA 
patients may have a primary myopathy of their genioglossus muscle leading to complete 
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loss of function at the onset of an apneic event and returning at the termination of 
obstruction (Chung et al., 2008; White, 1995). 
Patencies of these three collapsible regions of the pharynx are dependent on the 
inspiratory function of the three-dilator muscles. The larger the negative inspiratory 
pressure during respiration the stronger the force of pharyngeal contraction required from 
these dilator muscles to maintain patency of the airway. Pressure sensitive airway 
receptors are responsible for instigating the negative pressure reflex response. This is 
elucidated by the fact that the implementation of anesthesia effectively abolishes this 
reflex (White, 1995). Finally a group of three individual muscles grouped together as the 
hyoid muscles are responsible for enlarging and opening the laryngopharynx by elevation 
of the hypo- epiglottic ligament. The activities of these muscles are also phasic with 
respiration. Neck positioning and facial abnormalities can greatly affect the function of 
the hyoid muscles leading to narrowing of the laryngopharynx (Pierce et al, 1999; White, 
1995) Function of pharyngeal muscles and airway patency are critical during sleep. More 
specifically during REM sleep. Rem sleep is a very deep sleep and is characterized by a 
general loss of muscle tone as which has been demonstrated by electromyelographic 
imaging. It is during REM sleep that rhythmic activity of the upper airway muscles can 
cease completely, and upper airway resistance increases maximally. It has been noted that 
the most important region of collapse is within the lateral pharyngeal muscle walls. In the 
OSA patient apnea occurs when complete closure of the lateral pharyngeal walls occur. 
Gradations of weakness within the lateral pharyngeal walls during Non REM sleep 
results in audible snoring. Fluttering of weakened pharyngeal walls causes it. In general 
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the weaker the walls the louder the snoring and complete closure results in absence of 
sound (Wilson et al., 1999). Obesity has been found to be a direct cause of OSA due to 
increased fat deposition in the pharynx; which has been demonstrated by magnetic 
resonance imaging, to decrease airway patency (Mortimer et al., 1998). Furthermore, the 
fat deposition in OSA patients has been found to predominate in the lateral pharyngeal 
walls. The volume of pharyngeal wall fat correlates directly with the severity of OSA 
(Horner et al., 1989;Shelton et al., 1993). The deposition of fat not only narrows the 
airway in the OSA patient but it also changes the shape transforming the normal 
elongated lateral wall with an elliptical shape to a more anterior posterior axis with a 
rounded lateral wall and circular shape (Pierce et al., 1999). Studies denote that anterior-
posterior axis leads to less efficient function of the pharyngeal airway dilator muscles 
than an elongated elliptical axis (Leiter, 1996). 
Overall patency of the pharyngeal airway is determined by varying pressure exerted on 
the walls of the airway. The nasopharynx, oropharynx and laryngopharynx act like 
compressible tubes and both internal and external wall pressures affect the opening of 
such tubes. Transmural airway pressure is the difference between external and internal 
airway wall pressures. If this pressure is equal and constant then the airway remains open 
as long as the tissues remain compressible. In the obese patient external wall pressure are 
increased due to the increased fat deposits within the submandibular tissue. OSA patients 
typically present with short fat necks and "sagging jowl's". Davies et al, 1990-1992) 
found significant correlation with increased neck circumference and severity of OSA. 
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John L. Benumof (2002) defines obstructive sleep apnea as "cessation of airflow for more 
than 10 seconds despite continuing ventilatory effort five or more times per hour of sleep 
which is usually associated with a decrease in oxygen saturation of more than 4 percent" 
(p.790) A series of respiratory events occur during an obstructive apnea episode. As the 
duration of apnea increases pulmonary arterial oxygen tension (Pa02) decreases. Decreased 
Pa02 that in turn augments carotid body output causing vasoconstriction and increased heart 
rate causes arousal. 
Concurrently, pulmonary artery carbon dioxide tension (PaC02) increases, which 
stimulates central nervous receptors similarly eliciting arousal state. Ventilatory effort is 
promoted due to the fluctuations of Pa02 and PaC02 and intra-airway pressures become 
increasingly negative, increasing likelihood of airway closure. In this instance arousal 
may be initiated by pressure sensitive receptors in the upper airway (Benumof, 2002). 
The four mechanisms discussed lead to increased neural activity in the reticular activating 
system and arouse the individual. Snoring, sputtering, gasping, twitching or extremity 
movement may preclude the manner of arousal. The muscles of the pharyngeal airway 
open in response to the arousal and ventilation reoccurs (Benumof, 2002, p.796). 
The physiological events necessary for adequate ventilation are essential for the OSA 
patient to support life. The repetitive recurrence of these essential physiological processes 
have been found to adversely influence and enhance the occurrence of other disease 
disorders such as hypertension, cardiac arrhythmia, myocardial infarction, diabetes, and 
coronary vascular incidents (Chung et al., 2008). According to Seet et al. (2010) 
Obstructive sleep apnea has been associated with several co-morbidities cardiovascular 
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disease, including MI, heart failure, arrhythmias, hypertension, cerebrovascular disease, 
metabolic syndrome, obesity, and gastroesophageal reflux. (P.200) 
The occurrence of diagnosed obstructive sleep apnea patients has been estimated to be 
1 in 4 men (11.4%) and 1 in 10 women (4.7%). The statistics are even greater in the 
obese population; 7 of 10 obese individuals have been diagnosed with obstructive sleep 
apnea. Due to the increase of obesity within our nation, it is estimated that within the 
American population today a significant number of individuals; as many as 90%, may be 
undiagnosed with obstructive sleep apnea. (Benumof, 2002; Chung et al, 2008; Seet et al, 
2010) The presumption is the numbers will only increase, as the incidence of obesity 
remains unchanged and in fact growing statistically. It is estimated that the number of 
diagnosed and clinically presumptive sleep apnea patients will increase five to ten times 
by 2012 and continue to escalate thereafter. (Benumof, 2002) 
The implications for both a diagnosed and undiagnosed obstructive sleep apneic 
population of such vast numbers is increased medical and surgical risks and ultimately 
increased morbidity and mortality for these individuals during medical, surgical and 
perioperative management. Untreated obstructive sleep apnea significantly and 
independently increased the incidence of stroke or death from any other underlying 
cause. (Yaggi et al, 2003p. 2040) 
For Nurse Anesthetists and anesthesiologists; patients with undiagnosed obstructive sleep 
apnea pose greater risk of airway compromise and require additional measures and 
management regimes to ensure safe anesthesia care. 
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Obstructive sleep apneic patients have statistically difficult airways for intubation, 
increased sensitivity to anesthetic agents and a propensity for increased postoperative 
adverse events and complications. (Seet et al., 2010) 
Recent studies have demonstrated that patients with obstructive sleep apnea 
undergoing upper airway surgery, joint replacement surgery and cardiac surgery exhibit 
increased risk of postoperative complications. (Gupta et al, 2001; Kim et al., 2005; Liao 
et al., 2009; Pang et al., 2006) 
These findings are alarming and do not even represent the number of surgical or sedation 
patients who may arrive for anesthesia with undiagnosed obstructive sleep apnea. It is 
important that the OSA patient be preoperatively identified so that the anesthesia provider 
may provide the necessary treatment precautions to eliminate operative and postoperative 
complications and adverse events. 
The established gold standard for diagnosing obstructive sleep apnea is 
Polysomnography more commonly known as a sleep study. The purpose of 
polysomnography is not only to establish a diagnosis of OSA but also to determine the 
degree of severity of the obstructive airway disorder. The apnea hypopnea index (AHI) 
is the number of adverse respiratory events occurring per hour of sleep. The American 
Academy of Sleep medicine defines for mild OSA as 5- 10 AHI, moderate OSA as 15-30 
AHI and severe OSA as more than 30 AHI within one hour of sleep. Differing 
classification for OSA prevail for example the United States Medicare guidelines define 
OSA as an AHI of 15, or an AHI of 5 with 2 comorbidities and in Canada the accepted 
criteria is establishment of daytime sleepiness, without other definitive cause, or two 
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other symptoms of OSA. (i.e. choking/gasping during sleep, recurrent awakenings from 
sleep, daytime fatigue, impaired concentration) Duration of oxygen desaturation, rate of 
desaturation, adequacy of ventilator recovery, and level of arousal are other factors that 
have been incorporated to evaluate OSA. (Seet et al., 2006) (p.200) 
Even with the accepted gold standard of diagnosis "polysomnography" there exist 
problems with implementation of the test as well as accurate and consistent diagnosis of 
the degree of severity of this disorder. Polysomnography is time consuming (8 hour to 2 
consecutive night study), expensive, resource intensive, and not at all suitable as a short 
term screening device. (Chung et al, 2007) 
Eastwood et al (2010) cite an example of various studies in which the categorizing of 
AHI of 5 within a 1993 Wisconsin Study in the New England Journal of Medicine was 
the equivalent to a Chicago definition of a category AHI of 15. The absence of a global 
consensus of standardized criteria for the definition of the severity of OSA has significant 
impact on identification and comparative findings for research and methodologies. Lack 
of standardization has significant effects on OSA prevalence estimates, treatment 
decisions and the establishment of links between OSA and comorbidities. (Eastwood et 
al, 2010) 
In 2006, the American Society of Anesthesiologist attempted to provide consensus for 
the diagnosis of OSA as well as provide management guidance. A task force made up of 
a panel of 12 members including anesthesiologists, a bariatric surgeon, an 
otolaryngologist and two methodologists developed "Practice guidelines for the 
perioperative management of patients with obstructive sleep apnea". (Para. 3) The 
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purpose of this publication was to aid in the identification of the OSA patient within the 
preoperative interview and provide guidelines for perioperative management of their 
care. The establishment of these guidelines resulted in a format of fourteen categorized 
questions comprising a checklist of physical characteristics, identification of airway 
obstruction during sleep, and complaints of somnolence. All criteria established to be 
present and contributing to obstructive sleep apnea. The sensitivity of the task force's 
checklist was 79% to 87% as compared to the "gold standard" of Polysomnography. 
(Seet et al, 2010) Subsequently a more efficient, concise screening tool was developed 
called the STOP-BANG questionnaire. A meta-analysis of clinical screening measures 
for obstructive sleep apnea identified and evaluated 26 different clinical prediction tests, 
8 of these were survey questionnaires, and 18 algorithms, regression models or neural 
networks. The findings supported and recommended the STOP-BANG as a preoperative 
screening tool on the basis of ease of use and the excellence of predictability of severe 
OSA (AHI>30) with 96% sensitivity. The simple acronym STOP BANG and linear scale 
make the tool practical and very user friendly in the perioperative setting (Ramachandran 
et al., 2009). 
Additional information related to the existence of comorbidities is of great significance 
to the anesthesia provider. It is well established that untreated OSA results in greater 
morbidity and mortality in the perioperative period. (Bahammam et al., 1999; Bixler et 
al., 2000; Dykes et al., 1996; He et al., 1988;Hunge et al., 1990). Yet, the effects of OSA 
and coexisting disease in the perioperative setting have not been fully explained. Does 
OSA have a significant impact on underlying disease processes that lead to perioperative 
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complications? Several studies have drawn associations between patients with OSA, 
diabetes, cardiovascular disease, obesity, arrhythmias and stroke. 
Obstructive Sleep Apnea and Diabetes 
A high association between OSA and metabolic disorders would seem very likely since 
the link with severe OSA and obesity as a risk factor are so strong. There is growing 
evidence that OSA serves as an independent entity of risk for adverse glucose 
metabolism. Does OSA have a definitive role in the onset of diabetes? The mutual 
connections between obstructive sleep apnea and diabetes are still not fully understood. It 
is known that the glucose sensing process uses the same neurotransmitter pathways as the 
hypoxic sensing process. The carotid body glomus is the polymodel receptor that detects 
low blood glucose. Rasche et al. (2010) identified that the hypoxic events associated 
with obstructive sleep apnea combined with diabetes all signal responsive elements in the 
carotid body. This carotid gluco-sensor malfunction could be challenged and unable to 
initiate the regulatory process necessary to counter increased blood glucose. In this 
manner sleep apnea may increase the propensity for the development of diabetes, 
independent of other metabolic related processes. (Rasche et al, 2010) 
Chasens (2003) examined some of the theories that might explain the relationship of 
OSA and diabetes. Of definitive agreement among the theories is the centroid pattern of 
obesity occurring in persons with insulin resistant or diabetes Type 2. The existence of 
extra body weight increases the resistance on respiratory structures and leads to 
narrowing and collapse of upper airway tissue in OSA. Yet Stahl (2002) offered a 
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coexisting theory, that the hypoxia and hypercapnea that occur in OSA provoke 
sympathetic nervous system stimulation that results in hyperinsulinemia. The mechanism 
proposed for increased insulin resistance and glucose regulatory dysfunction is the result 
of repetitive hypoxia and hypercapnea, which occurs with apneic events, triggers the 
stress response invoking chemoreceptors in carotid bodies, aortic arch and in the medulla 
of the brain. 
The results of these processes are the release of catecholamines: epinephrine, 
norepinephrine and Cortisol. OSA interferes with glucose management by insulin 
deregulation (Chasens et al., 2003) (p.89). A study by Mahmood et al. (2009) also 
supports the sympathetic response theory citing "severe OSA results from increased 
neurogenic sympathetic activity and circulating levels of norepinephrine" which 
predisposes to increased glycogenolysis, lipolysis, and insulin resistance. (P.219) 
Another study by Eastwood et al. (2010) described obesity (excess adipose tissue) as 
a" cofounder or active partner in crime" when evaluating the impact of OSA on 
metabolic disorders (p. 590). If this were fact then you would expect that a relationship 
with OSA and the development or existence of diabetes would depend on the amount of 
adipose or fat cells the individual with OSA exhibits. Normal or lean BMI OSA 
individuals would be unlikely to have diabetes. Speculation would seem to favor the fact 
that body fat would be the greater modulator of diabetes rather than OSA since body fat 
has direct impact on cause of diabetes. Yet, published studies suggest that OSA may 
impair insulin secretion, leading to glucose intolerance or diabetes. This physiological 
manifestation of an insulin- resistant state has little to do with obesity. Ultimately the 
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"lean" OSA individual may still suffer from diabetes. (Ip et al, 2002; Punjabi et al, 2009) 
Steiropoulos and colleagues (2009) conducted a study of 31-year-old males newly 
diagnosed with OSA without diabetes and found significant correlations between 
glycolated hemoglobin levels and AHI as well as arousal index and percentage of sleep 
time with hemoglobin saturation less than 90%. The correlations suggest that OSA posed 
a significant risk factor for glucose dysmetabolism irrespective of the presence of 
diabetes. The authors suggest the need for addressing preexistence of OSA in both 
diabetic and non-diabetic patients to effectively assess glycemic control. Additional 
studies have shown strong associations between OSA, glucose intolerance, insulin 
resistance and diabetes independent of obesity. A 2010 study by Arhonson indicated a 
high prevalence of OSA in patients with diabetes Type-2. The existence of a graded and 
inverse relationship between OSA severity and glucose control was demonstrated in 
patients with Type 2 diabetes, after controlling for the degree of obesity (BMI), age, and 
gender. Furthermore the study may have significant implications to support a hypothesis 
that reducing the severity of OSA may improve overall glycemic control in diabetes Type 
2 patients and prevent onset for the non-diabetic OSA patient. 
A pilot study completed at Grenoble University in France consented 40 subjects with 
Type 1 diabetes to be screened for obstructive sleep apnea. Sixteen of the 40 subjects 
were determined by Polysomnography to have OSA. In addition, 10 of the 16 subjects 
were classified with severe OSA. A total of 40% of the Type 1 diabetic subjects were 
determined to have obstructive sleep apnea; this is an exceptionally high percentage. The 
subjects were all of normal body habitus, not obese and BMI was not associated with 
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pathological oximetry values. The pilot studies suggest a linkage between pharyngeal 
neuropathy and high prevalence of OSA in Type 1 diabetic subjects. In a similar study 
Ficker et al. 1998 demonstrated that obstructive sleep apnea was associated with 
autonomic neuropathy in Type 2 diabetics (Borel et al, 2010). 
In a United Kingdom a sample of 938 subjects with diabetes were recruited from a 
tertiary hospital clinic and five primary care clinics within the community. Sleep studies 
were obtained and prevalence of OSA was found in 23% of the respondents as compared 
to 6% of the non-diabetics within that general community (Foster et al., 2009). A 
Canadian study of 2,149 subjects; 8.1% were diagnosed with diabetes and a twofold risk 
of OSA was found in the diabetes group when compared to the non-diabetic group, 
despite adjustment for potential confounders (Ronskley et al., 2009). Elmasry (2001) 
conducted a longitudinal study in Sweden looking at the relationship of diabetes, 
hypertension and OSA. One hundred sixteen hypertensive subjects with OSA were 
selected. They found that although obesity is strongly associated with the coexistence of 
diabetes mellitus, severe OSA seems to add significantly to this association, Their 
comparative study included 4 groups of hypertensive men (Non-OS A: non-obese, Non-
OSA: obese, OSA: non-obese and OSA: obese) the highest percentages of diabetes 
occurred in the subjects with OSA: Obese. But of significance to the authors, 35% the 
second highest incidence of diabetes was in the OSA: non-obese group. Elmasry et al. 
conclude that following linear regression their data supported significant association 
between AHI and fasting blood glucose, fasting serum insulin, and HbAlc levels. Using 
multiple regression desaturation index also demonstrated significant association with 
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fasting serum insulin, fasting blood glucose and glycohemoglobin -HbAlc. (p. 15 8) This 
data supports the evidence that obstructive sleep apnea has independent and significant 
adverse effects on fasting serum insulin, blood glucose and HbAlc when adjustments are 
made for central obesity, even in normoglycemic hypertensive males (Elmasry et al., 
2001) 
Associations of OSA and glucose disorders are not limited to western culture alone. In 
a 2009 Japanese longitudinal study; subjects with nocturnal intermittent hypoxia 
exhibiting AHI <5 and lowest Sp02 during the night were associated with an increased 
risk of type 2 diabetes independent of the traditional risk factors of age, gender and BMI 
(Muraki et al., 2010). Another study conducted in Japan 2010 examined the prevalence 
of OSA associated with Type 2 diabetes. Of the 165 subjects that underwent 
Polysomnography 89 were found to have clinically diagnosed OSA. The prevalence of 
associative OSA and Diabetes in the Asian population was 53.9%, with 18% having 
severe OSA and 15% classified as moderate OSA. In Japanese, 40 to 60 years old, the 
study denotes a threefold increase in men (32% vs. 10%) and a twofold increase in 
women (14% vs. 6%) with associative OSA and diabetes as compared to the general 
population. The actual numbers of OSA and diabetes occurrence are more representative 
of findings in the United Kingdom and Canada (Lam et al., 2010). 
When examining the incidence of OSA and diabetes within different ethnic and age 
subgroups it was determined that Hispanics had a high prevalence of Type 2 diabetes. It 
was also observed that the occurrence of Type 2 diabetes in middle-aged subjects with 
OSA was 2.8 times higher than in younger or middle aged subjects without OSA. Older 
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subjects had higher odds of Type 2 diabetes regardless of OSA status. This may allude to 
a genotype component responsible for diabetes disorders regardless of OSA (Mahmood 
et al., 2009). 
The Center of Disease Control estimates the number of individuals in the United States 
with diagnosed and undiagnosed diabetes to be around 24 million. The prevalence of 
diagnosed obstructive sleep apnea in patients with Type 2 diabetes ranges from 73 to 86 
percent, this suggest a staggering number of individuals; approximately 17 million people 
with diabetes are unaware of a significant co-morbidity. This is a major concern for 
those in the medical profession, and more specifically for the anesthesia provider whose 
delivery and management of care is directly influenced by the associated effects of 
obstructive sleep apnea and diabetes. (Pamidi et al, 2010) 
Obstructive Sleep Apnea and Cardiovascular Disease 
A growing body of evidence supports obstructive sleep apnea as an important risk 
factor for hypertension related cardiovascular disease and dysrhythmias. Lavie and 
associates (2001) estimated that approximately 40 to 60 percent of individuals diagnosed 
A 
with obstructive sleep apnea in sleep labs had concurrent hypertension. This rate of 
hypertension was two to three times greater than the general population. Since OSA 
prevalence has increased to an estimated 34% (diagnosed and undiagnosed) of the 
population in the last ten years; the increase in hypertension will also have grown 
exponentially. 
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A number of studies have elicited theories describing the physiological processes for 
OSA's contribution to hypertension and arrhythmia disorders. Ryan et al (2009) suggest 
that inflammatory processes leading to endothelial disturbances play an essential role in 
the pathogenesis. The repetitive hypoxia -hypopnea events that occur in OSA create 
short cycles of desaturation followed by rapid re-oxygenation, initiates the inflammatory 
process. This intermittent re-oxygenation resembles the same characteristics of 
reperfusion injury and is proposed to result in the development of atherosclerosis. 
The inflammatory markers known as cytokines and chemokine's (adhesion molecules) 
are precursors in the pathogenesis of atherosclerosis and are potential cardiovascular risk 
markers. These inflammatory markers have been identified as independent risk factors 
for cardiovascular diseases (Ryan et al., 2009). The cytokine Tumor Necrosis Factor 
Alpha (TNF-a) is recognized as important in the development of atherosclerosis. 
Circulating levels of TNF- a have been indicators for early signs of atherosclerosis in 
middle aged men and are predictive for coronary heart disease and congestive heart 
failure. Studies examining levels of TNF-a with obstructive sleep apnea syndrome have 
consistently shown elevated levels of the cytokine in OSA subjects in comparison to 
controls and independent of obesity. These same studies have demonstrated significant 
reduction in TNF-a following implementation of continuous positive airway pressure 
(CPAP) therapy. So, TNF-a levels could be the best predictors of cardiovascular risk for 
the individual with obstructive sleep apnea (Ryan et al., 2009). 
Another chemokine, Interleukin- 8 (IL-8) has been found to be associated with OSA. 
IL-8 is another precursor to atherosclerosis; it plays a major role in plaque destabilization 
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and atherogenesis. IL-8 levels were notably increased with OSA and similar to TNF-a 
response; IL-8 levels demonstrated a significant reduction when CPAP treatment was 
initiated within the study. Both the cytokine TNF-a and the chemokine IL-8 are 
modulated by the same transcription factor Nuclear Factor Kappa B (NF-k B). This 
transcription factor plays a predominate role in initiating the inflammatory process and its 
effect on the other mediators supports the role of OSA in inflammatory response and 
cardiovascular disturbances (Ryan et al., 2009). Yamauchi et al (2008) identified similar 
processes as the Ryan study and cite the contribution of the inflammatory process and 
immune response to the development of atherosclerosis. Atherosclerosis is identified 
as the "common pathological factor for cardiovascular disease" (p.756) This study 
similarly identifies the hypoxia-re-oxygenation as the component of OSA causing the 
inflammatory process. The study also demonstrated that OSA induced intermittent 
hypoxia activated NF-k B and that this activated transcription factor induced the 
inflammatory responses in the arterial walls that impairs endothelial function leading to 
cardiovascular consequences. The re-oxidation and reperfusion phase results in the 
production of reactive oxygen species (ROS). ROS reactive molecules damage intimal 
cells and promote oxidative stress. A number of studies have reported markers of ROS 
are associated with OSA. These two articles found similar conclusions: inflammatory 
response and endothelial dysfunction lead to the pathogenesis of atherosclerosis. 
Transcription factors, chemical mediators: cytokines, chemokines, markers of oxidative 
stress are likely activated by OSA - related oxidative stress (hypoxia-reperfusion) and 
may define the pathway in the cardiovascular consequences of OSA (Yamauchi et al., 
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2008). The first direct evidence at the cellular and molecular level, of the impact of 
oxidative stress on the endothelial cells was determined by Padelletti et al (2008). They 
found that the endothelial nitric oxide synthase (eNOS) and its phosphorylated active 
form (p-eNOS) were weakened in the OSA patient and that the oxidative stress marker 
nitrotyrosine, which is an indicator of nitric oxide inactivation by oxidative stress, was 
elevated, (p. 3469) 
Mansfield and Naughton (2005) described evidence of OSA's causation and progression 
of congestive heart failure and cardiovascular disease including hypertension. Cardiac 
preload and afterload are affected by intra-thoracic pressure. The fluctuations of 
intrathoracic pressure (exaggerated falls of intrathoracic pressure) created by repetitive 
ventilator efforts against closed airway occurring during the hypoxic- re-oxygenation 
episodes of OSA create conditions of increased left ventricular afterload and decreased 
preload. The result is overall reduction in stroke volume and cardiac output which over 
time progresses to congestive heart failure (CHF) (Mansfield et al., 2005). Kato et al 
(2000) and Gami et al (2005) studies found a relationship between OSA syndrome, 
sudden death, and nocturnal myocardial infarction. Repetitive cycles of bradycardia and 
tachycardia are commonly documented during sleep studies of the OSA patient. Severe 
sinus bradyarrythmias are prevalent in OSA patients with severe hypoxemia, especially in 
rapid eye movement (REM) sleep. Severe hypoxemia during REM sleep may predispose 
OSA patients to abnormal heart rhythms such as extreme bradycardia, sinus pauses, or 
conduction blocks. Evidence from previous studies also supports an independent 
association of OSA and atrial fibrillation (Lavie et al., 2008). 
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The effects of hypoxia, hypercapnea, baroreceptor desensitization, and arousal 
responses are all factors that contribute to both the acute and chronic augmentation of the 
sympathetic nervous system. Sympathetic nervous system activation remains the most 
likely and consistently identified explanation for the development of chronic 
hypertension (Mansfield et al., 2005). It has been demonstrated that patients with OSA 
do not exhibit the normal nocturnal "dipping" of blood pressure during sleep. Non-
dipping nocturnal blood pressure remains a characteristic factor in underlying OSA 
distinct from the hypertensive population without OSA, which may prove valuable as a 
diagnostic measure (Portaluppi et al., 1997). 
Various studies have encouraged the incorporation of CPAP to OSA patients as 
restorative treatment for hypertension and CHF. Malone et al (date) found a 12% 
improvement in left ventricular ejection fraction (LVEF) when CPAP via nasal cannula 
was introduced for 4 weeks to their subjects diagnosed with idiopathic dilated 
cardiomyopathy. In another study, 24 patients with CHF and OSA were randomized to 
one month CPAP or no treatment groups. The CPAP treatment group demonstrated an 
8.8% improvement in their left ventricular ejection fraction and a fall in mean systemic 
blood pressure of 10mm hg was also reported. (Kaneko et al., 2003) 
A controlled paralleled trial of 118 patients with hypertension and OSA underwent CPAP 
treatment and mean systemic blood pressure fell by 2.5mmhg over 4 weeks. (Peperell et 
al, 2002) The result was more pronounced in the more severe OSA group with 
hypertension; mean systemic blood pressure dropped by 6.6mmhg. In these studies 
CPAP appears to lower blood pressure and LVEF by eradicating obstructive sleep apnea-
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hypopnea. In a study of untreated hypertension in middle aged men with undiagnosed 
mild OSA (AHI > 5) and without OSA the mean change in nocturnal blood pressure 
during and after 3 weeks of nightly CPAP was significantly greater in the mild OSA 
patients adjusted for age and BMI. The CPAP treatment did not affect the blood pressure 
of non-apneic subjects (Marrone et al., 2003). The effectiveness of CPAP therapy in 
improving cardiovascular disorders such as hypertension, and idiopathic cardiomyopathy 
provides strong evidence that obstructive sleep apnea and its resultant hypoxic-hypopnea 
events have a direct effect on cardiovascular function. The association of obstructive 
sleep apnea events and endothelial dysfunction, oxidative stress, inflammatory pathways, 
and sympathetic nervous system response warrants direct concerns for physicians and 
anesthesia providers alike. The high prevalence of OSA and its close association with 
cardiovascular dysfunctions lead too much greater risk for morbidity and mortality. 
Adverse outcomes will definitely result if these associative disorders are not identified, 
addressed, and corrected. 
Post-operative Complications with OSA 
The risk of serious postoperative complications has been previously addressed in 
regards to obstructive sleep apnea alone. Most OSA patients have sleep disorders 
involving both REM and Non REM sleep. Nocturnal apneic events coupled with 
preoperative anxiety; common prior to surgery, leads to overall poor sleep quality, and 
sleep deprivation prior to surgical events. This causes many patients to experience post­
operative REM rebound characterized by increased episodes of airway atony and 
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subsequently airway collapse. This phenomenon can occur up to the third or fourth 
postoperative day when patients have returned home (Pang, 2006). Benumof (2004) 
found supporting evidence that in the postoperative setting, sleep mechanics were 
disturbed due to the requirement for increased analgesia for surgical pain. Analgesia 
through the first three days after surgery tended to incur a life threatening apnea from 
drug-induced sleep. He also described rebounds in REM sleep originating from poor 
quality sleep this was believed to increase the danger of a detrimental natural deep sleep-
induced apnea. He suggested that patients with OSA are at risk of prolonged apnea 
during sleep for up to one week in the postoperative period. 
Correlations between hypoxic events and episodes of recurrent oxygen desaturations 
associated with adverse outcomes have been reported. Gupta et al (2001) examined 
procedure specific complications in the post operative period and found that OSA 
patients experience significantly more occurrence of complications than the group 
without OSA. Complications included acute hypercapnea, PaCo2 >45, episodic 
desaturations reflected by Sp02 <90% with witnessed apneic events; arrhythmias, MI, or 
infarction, and delirium. 
In the United Kingdom a mailed survey was provided to a group of anesthetists to define 
perioperative care of adults with OSA: Perioperative complications included 34% 
difficult intubations, 47% difficult ventilations, 24% cardiovascular instability, difficult 
analgesia in 41%, difficult extubation 13%, postoperative apnea 46%, required 
reintubation 27%, unplanned ICU admission 23%, and acute cardiac events 
25%(Bamgbade et al., 2009). 
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These findings support the need for accurately assessing the postoperative status of 
OSA patients and determining criteria for risk assessment. Studies have shown strong 
relationships between the numbers of oxygen desaturations episodes within the post 
anesthesia care unit to occurrence of adverse events. Questions could be posed regarding 
the causes of the postoperative complications. OSA attributed events such as: Hypoxia, 
Hypopnea, Hypercapnea, snoring etc. Are they independently caused by the OSA 
disorder? Or is their synergistic component with other cofactors (HTN, Diabetes, CVD) 
that creates the adverse events? Does the OSA patient with one or more cofactors have 
more adverse events and do they require a longer PACU stay? 
There currently is no clear explanation. It would be valuable information for the 
anesthesia provider and other health care providers to know the most significant cause of 
adverse events in the OSA patient. 
Preoperative assessment of all surgical patients using validated instruments would aid 
in the identification of those patients with both known OSA and more importantly 
identify those that are unknown. Cofactors can be identified and appropriate optimization 
measured can be applied. Intraoperative management could be streamlined and specified 
for the OSA patient in a manner that minimizes complications. Postoperative measures 
and protocols could be developed to improve the care for the OSA patient; eliminating 
the risk factors and provision for safe analgesia that inhibits heavy sedation while 
promoting optimum oxygenation. 
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Theoretical Framework 
An English physiologist Ernest Starling identified a theoretical phenomenon of vessel 
capacitance as influenced by flow, forces, and pressure. The Starling Resistor Theory 
(Stalford, 2004) explains the function of fluid flow through the coronary arteries. The 
Starling Resistor Theory is offered as a theoretical framework to compare and contrast 
airway physiology and function within the normal adult airway and in the OSA airway. 
The Starling Resistor Model (Stalford, 2004) can be readily applied to describe flow in 
the upper airways. The concept provides an excellent explanation of airway dynamics as 
influenced by changing forces or pressures. A resistor is described as a collapsible tube 
passing through a chamber that is capable of having it's pressure changed. For 
application purposes we can identify the oropharynx as the tube and the surrounding 
tissue of the neck as the chamber. If the oropharynx remains open then airflow will be 
determined by the pressure differences from the two sides of tissue within the neck; from 
the pressure above; the proximal region of the nose or mouth and from the pressure 
below; the distal portion of the trachea. 
The main characteristic dysfunction of OSA is obstruction of airflow. The patient with 
OSA has recurrent apneic events that are the result of a closed or "blocked" airway that 
occurs during sleep. To understand the co-existing factors that may contribute to the 
adverse affects of OSA we must first understand the anatomic and physiologic process 
that defines OSA. The airway of the OSA patient presents differently than that of a 
typical adult airway. An OSA patient's airway is smaller and narrower in contrast. The 
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OSA airway has a more lateral axis while the typical adult airway is more horizontal. 
This variant is thought to be caused by an excess of redundant tissue. In fact a definitive 
feature of OSA patients is an increased neck circumference or "thick neck" (Benumof, 
2004). When sleeping the oropharyngeal muscles of the adult airway are relaxed and 
pharyngeal narrowing occurs and there is increased negative inspiratory pressure 
especially during rapid eye movement (REM) sleep. Additional negative inspiratory 
pressure is generated by diaphragmatic excursion and pharyngeal dilator muscle activity 
is incorporated as a compensatory mechanism, which maintains airway patency in the 
normal adult. In the OSA patient, pharyngeal dilator muscle activity maintains patent 
during awake periods but the muscle activity is lost when the OSA patient is asleep. 
Excessive adipose tissue in the neck of the OSA patient surrounds the oropharynx and 
compresses the airway making muscular activity less effective. Increased negative 
inspiratory pressure along with snoring, which can cause vibratory trauma can further 
enhance upper airway narrowing (Woodson et al., 1991). 
The tissue pressure (Ptissue) corresponds directly to the pressure surrounding the tissues 
of the oropharynx that constrict the upper airway. A high opening pressure (Pproximal) 
will assist in overcoming the collapsing pressure of tissue (Ptissue). A low or negative 
pressure below the vocal cords (Pdistal) that occurs as a result of the inspiratory effort 
will contribute to airway collapse if Ptissue is elevated. When sufficient muscular tone is 
operative in tissues surrounding the collapsible tube, the effect is a "lifting of the tissue 
"away from the collapsible portion. Thus Ptissue does not contribute to airway 
collapse. (Stalford, 2004) 
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Figure 1. Starling Resistor Model 
Pd (distal)=upstream pressure, Pp (proximal)=downstream pressure and Pt 
(tissue)=pressure in the chamber (Stalford, 2004). 
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In the OSA patient, arousal is essential for airway patency and survival. A lack of 
oxygenation leads to hypoxemia and hypercarbia. Increased levels of C02 stimulate 
chemoreceptors within the CNS, which in turn release neurotransmitters promoting 
arousal. Reflex response activates pharyngeal dilator muscles and airways open, 
ventilation is returned. (Kaw et al, 2006) 
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Figure 2. Sleep Apnea Cycle 
Starlings Resistor Theory was formulated to explain the properties of vascular 
compliance and resistance forces. The theory has already been established and accepted 
as defining the properties of fluid flow through blood vessels, and vascular circulation. 
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Although the coexisting factors of hypertension and cardiac disturbances in the OSA 
patient are not fully understood, an association with flow, increased pressure, and 
collapsibility may offer an explanation using Starling's Resistor Theory (Stalford, 2004). 
Applying this theoretical framework for both airway and hemodynamic pressures is 
appropriate and could indicate symbiotic relationships 
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CHAPTER 3 
METHODOLOGY 
The purpose of the study is to identify preexisting factors that significantly impact 
postoperative recovery times for patients undergoing surgical procedures. The research is 
informed by the Starling Resistor Theory (Stalford, 2004). The relationship and 
associations of pre-existing disorders such as hypertension (HTN), diabetes (DM-II), 
cardiovascular disease, and body mass index (BMI) in obstructive sleep apnea (OSA) 
patients will be investigated as co-factors in PACU recovery times. Hypertension, 
cardiovascular disease, and diabetes are prevalently reported as confounding and 
coexisting factors in obstructive sleep apnea patients. (Dykes et al, 1996). Yet there is no 
evidence as to whether these cofactors have any deleterious affect on post surgical 
recovery times of sleep apnea patients. This chapter presents the research methodology 
including design, sample and sampling, data collection procedures with instrumentation, 
and data analytic procedures. The protection of human subjects is also discussed. 
Design 
A quantitative observation correlational design method will be utilized for the proposed 
study. Determining a relationship of postoperative ambulatory care unit (PACU) stay 
times between obstructive sleep apnea patients and those without sleep apnea following 
elective abdominal surgery. The relationship and associations of pre-existing disorders 
such as hypertension (HTN), diabetes (DM-II), cardiovascular disease and GERD in 
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obstructive sleep apnea (OSA) patients will be investigated as co-factors in PACU 
recovery times. Munro (2005) states correlational techniques are used to study relationships. 
They may be used in exploratory studies, when the intent is to determine whether relationships 
exist, or in hypothesis testing studies, in which we test a hypothesis about a particular 
relationship, (p. 239) 
Based upon a review of the literature the relationship between OSA and the cofactors 
of hypertension, diabetes, and cardiovascular disease have been identified. Data findings 
have reported each cofactor's independent relationship with OSA. It is beneficial to this 
study to investigate the correlations of several cofactors and their relationship with OSA. 
Additionally, to provide the body of evidence as to which cofactors more significantly 
affect the occurrence, prevalence and adverse effects of OSA. 
SAMPLE 
A purposive sample of active duty, retired, or family members of military service 
members who have consented to elective surgery at the Naval Medical Center San Diego 
(NMCSD) and received a score of 5 or greater from preoperative evaluation using the 
STOP-BANG screening measurement will provide data for the proposed study. 
Inclusion Criteria consists of males and females 18 to 65 years, who have elected to 
have general anesthesia, surgery, category ASA I - III, able to read and comprehend 
English. Exclusion Criteria consisted of members above who had pre-existing pulmonary 
disorders (COPD, etc.), neurological dysfunction, delayed or decreased cognitive 
function and recent MI. 
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SAMPLE SIZE CALCULATION 
For the purpose of this study which is to determine if identified obstructive sleep 
apnea (OSA) patients have longer PACU recovery times as compared with non-OSA 
patients undergoing elective surgery and if their is an association between OSA patients 
with pre-existing factors (HTN, Diabetes, Cardiovascular Disease, BMI, type of surgery) 
and extended PACU recovery times. A multiple linear regression will be used to analyze 
the data. There is no consensus on mechanisms determining samples; several 
mathematical formulas exist along with computer program power analysis software to 
help determine appropriate sample size. These formulas and software programs assure 
that the number of participants selected for the study provide enough information to 
establish a valid correlation of event and outcome. Computer programs give an adjusted 
R2 (correlation) as well as an actual R2 (Munro, 2005) This type of computed formula is 
referred to as a shrinkage formula because of the relationship between the predictive 
values of actual vs. adjusted R2. Calculated math formulas vary, Cohen for example 
establishes effect size; Nunnally and Bernstein 1994 suggest that 10 subjects per 
predictor is a minimum "in order to even hope for a stable prediction equation" (p.201). 
Published studies have cited occurrence of OSA in western populations within 
the range of 23-38%. (Benumof, 2004 Seet et al 2010, Eastwood, 2010 Chung et al 2008) 
More specific approximation of incidence of OSA in surgical patients falls within 24-
26%. (Chung et al, 2008) The sample size for this study will be based on the consensus of 
data establishing a 26% occurrence rate. Utilizing Nunnally and Bernstein (1994) and 
Katz (2006) guidelines of ten subjects per predictor, 50 subjects with OSA would be a 
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minimum. Considering the incidence of OSA in the surgical population of 26% the 
estimated sample size for this study is 100 subjects. 
SETTING 
Data collection for this research will take place in the preoperative clinic, main 
operating room, and post-operative acute care unit of the Naval Medical Center San 
Diego (NMCSD). NMCSD is the largest naval military medical center within Naval 
Medicine West Region. The navy medical center averages 1,340 surgical cases a month, 
performing a variety of surgical procedures for numerous specialty medical services. It 
provides treatment and procedures for the largest number of military beneficiaries in the 
Western United States. 
MEASUREMENT 
Obstructive Sleep Apnea is caused by physiological closure of the oropharyngeal 
airway during sleep and will be assessed and defined by utilizing the STOP-BANG 
screening parametric, a concise and simple to use screen specifically developed to assess 
OSA criteria. Use of a previously established database evaluating OSA using the Stop-
Bang Measure will be incorporated. The database was generated in a phase one potion of 
this cumulative research. Stop-Bang is an 8-question (item) assessment that has been 
implemented and validated for use in defining OSA criteria in a surgical patient 
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population (Chung, 2008). OSA is defined by a greater than 5 score determined from 
responses to the 8 questions. 
The STOP Bang Questionnaire is made up of 8 questions related to: 
1). Snoring 
2). Tiredness 
3). Observed Apnea during sleep 
4). High Blood Pressure. 
5). BMI (Body Mass Index) 
6). Age 
7). Neck Circumference 
8). Gender 
It is a self- report, short answer /choice (yes/no) paper and pencil scale that takes an 
estimated 1 minute to complete. 
RELIABILITY AND VALIDITY 
Factor Analysis was completed and 4 underlying factors emerged for the 14 
questions related to snoring, tiredness, apnea and hypertension. Four questions were 
chosen that best represented the factor criteria in the simplest report format. Validity was 
determined via a pilot study comparing results from the STOP questionnaire to the 
established OSA measurement of polysomnography (sleep study). The sensitivity of the 
STOP questionnaire was 72%, the specificity was 33.3%, the positive predictive value 
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75%, and the negative predictive value was 30%. Reliability was established via test-
retest. Fifty-five patients answered the STOP questionnaire twice during a time interval 
of 1-27 days (median 8 days); 53 (96.4%) of the patients had the same score upon 
retesting. It was also demonstrated that the positive predictive value greatly increased in 
groups with: BMI > 35 kg/m2, age > 50 y/o, neck circumference > 40cm, and male 
gender. Thus a STOP-BAG measurement has been adapted for even greater reliability 
that includes B- BMI, A- age, N-neck circumference, and G-gender. (Chung, 2008) 
ALDRETE SCORE 
Protocols are utilized to immediately assess a patient's recovery from anesthesia 
after surgery. PACU guidelines govern different phases of the anesthesia recovery 
process these include early recovery, intermediate recovery, and late recovery. In Phase I, 
following the anesthesia providers report, PACU nurses implement a scoring system or 
scale to continue assessment of the patients. The Aldrete Score is a universally used 
scale, which scores the patient on mobility, respiratory status, circulation, consciousness, 
and pulse oximetry. The Aldrete score was formulated in 1970 and modified in 1992. 
Aldrete uses a rating scale of 0 thru 2 to score the five physiological criteria previously 
listed. A score of 2 in each category is considered best in all areas. The patient is 
discharged from the PACU when he/she meets the established criteria. A patient must 
attain an overall score of at least 9 to be considered for progression and discharge. 
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DATA COLLECTION PROTOCOL 
Patients scheduled for elective surgery are directed to the preoperative clinic to 
complete a preoperative questionnaire. This questionnaire identifies patient having any 
pre-existing disease factors such as hypertension, diabetes, suspected, or diagnosed 
obstructive sleep apnea. These patients are flagged and required to have a more in depth 
assessment by an anesthesia provider prior to their surgery, this could occur anytime 
between 1 and 14 days prior to their elected procedure. The preoperative nursing staff 
hand out the STOP- BANG measurement questionnaire along with the standard 
preoperative questionnaire. The preoperative score the STOP-BANG tool; patients with a 
score of 5 or greater will receive further assessment from an anesthesia provider. Any 
other preexisting factors will be identified and assessed by the anesthesia provider at this 
time. 
Phase I. A computerized data query comprised of research study criteria was completed. 
The primary investigator reviewed query results and compiled a purposive list of 
participant medical records containing the required data criteria for the study. A 
purposive sample of medical records was pulled and all data was obtained and recorded 
by the primary investigator. Data management and security was maintained in 
compliance with HIPAA standards and those of the Clinical Investigations Department 
(CID) at NMCSD. 
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Phase II. Data collection will consist of anesthesia assessment record review, Innovian 
electronic anesthesia intra-op and post-op record review, essentris electronic record 
documentation review from PACU and SDS environments. During record review 
demographic data will be recorded to include age, gender, BMI. In addition PACU 
recovery time, medications, existing cofactors, type and length of surgical procedure and 
complications will be recorded. Aldrete and PADSS information and score will be 
reviewed. STOP BANG measurement questionnaire reviewed and evaluated. CPAP use 
determined. EKG's will be verified if subjects have HTN, cardiovascular disease or 
cardiac arrhythmias. Baseline blood glucose will be recorded from patients with DM-II. 
Time frame for this period was approximately 20-30 minutes per medical record review. 
Area Specific Information includes: 
a. Pre-Op Hold Area: existing cofactors, day of surgery medications, NPO status, 
surgical procedure, review of systems, pain assessment. 
b. Intra-Operative Data: Information obtained from electronic anesthesia record 
(Innovian) includes intraoperative anesthetic, pain medications, muscle relaxants and use 
or non-use of relaxant reversal medications. 
c. Post Operative Data: Aldrete scores, PADSS scores, recovery times, incidence 
of desaturations (02 Sat < 90%), pulse oximetry measurements, CPAP use, FS blood 
glucose (DM-II pts.), hypertension documentation, medication treatments for pain and 
any other co-existing factors (essentris computer record). Additional Data: Any 
admissions to ICU will be followed and study data will continue to be documented until 
discharge from ICU. (Electronic record) 
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The Data collection protocol can be viewed in Appendix C. 
STATISTICAL ANALYSIS 
Specific Aims: 
Aim 1. To examine (or characterize) sleep disturbed breathing (OSA), 
hypertension, cardiovascular disease, diabetes, and postoperative recovery time, in a 
cohort of patients undergoing surgical procedures. 
Aim 2. To describe the relationships between sleep disturbed breathing (OSA), 
hypertension, cardiovascular disease, diabetes, and postoperative recovery time among a 
group of patients undergoing surgical procedures. 
Aim 3,4, 5- Analyze the covariance of independent variables within the two 
separate surgical groups. 
Aim 6,7 - Examine the relationships that the independent variables (HTN, DM-II, 
CVD) have on postoperative recovery time. The dependent variable of postoperative 
recovery time (PORT) will be examined as a categorical variable (PORT longer or not) 
Research Questions: 
1). Examine the relationship of OSA patients with incidence of HTN, DM-II, Cardiac-
arrhythmia, CVD, and BMI having elective surgery under general anesthesia. 
2). Examine the relationship of Non-OS A patients with incidence of HTN, DM-II, 
Cardiac arrhythmia, CVD, and BMI having elective surgery under general anesthesia. 
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3). Examine the relationships between patients with OSA and prevalence of HTN, 
Cardiovascular Disease, DM-II, GERD, gender, age, BMI, surgical procedure 
compared to a group of non- OSA patients after elective surgery under GETA. 
4). Characterize postoperative recovery time of OSA patients with incidence of HTN, 
DM-II, Cardiovascular Disease, BMI and GERD having elective surgery under general 
anesthesia. 
5). Characterize postoperative recovery time of Non- OSA patients with incidence of 
HTN, DM-II, Cardiovascular Disease, BMI and GERD having elective surgery under 
general anesthesia. 
5). Examine which predictors (HTN, Cardiovascular Disease, DM-II, BMI, GERD, 
surgical procedure) account for explained variance in Post Operative Recovery Time. 
6). Examine the relationship between severity or degree of OSA (mild, moderate and 
severe) and length of postoperative recovery time. 
Descriptive statistics were computed for demographic data such as age, gender, 
marital status, medications, and incidence of sleep study. Descriptive statistics were 
incorporated to examine pain occurrence, type of surgery and length of surgery. 
PROTOCOL 
The primary investigator (PI); a privileged ad working staff member in the 
preoperative,main operative, and postoperative areas of NMCSD; with granted permitted 
access to the medical records of study participants for the duration of the data-collecting 
period. IRB approved co-investigators had authority to review pre-operative, 
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intraoperative, and postoperative data from identified subjects. Incorporating co-
investigators ensured maximum enrollment, accuracy and accountability of the data. 
Study integrity is vital for data accuracy and validity. 
PROTECTION OF HUMAN SUBJECTS 
The collection of non-invasive medical record data involves a minimal risk to subjects. 
"Minimal risk" is defined as risks no greater than those experienced in everyday life. An 
inclusion criterion for this particular study involved the subjects electing to have a 
surgical procedure requiring general anesthesia. The surgeon and anesthesia provider 
had already obtained the subjects consent for surgery with general anesthesia. Therefore 
no additional risk is incurred as a participant of this study. All safety precautions, 
procedures, and requirements ensured for the preoperative, intraoperative and 
postoperative portions of this study were maintained. Direct consent for record review 
was not required; IRB approval was obtained and documented as phase II component of a 
Phase I preliminary study. Phase I: "STOP BANG TOOL TO DETECT 
OBSTRUCTIVE SLEEP APNEA FOR THE PERIOPERATIVE PATIENT" 
SAFETY PRECAUTIONS AND EMERGENCY PROCEDURES 
The data for this study will be obtained from medical records from surgical 
participants from the Naval Medical Center San Diego, a large Naval Medical Training 
Facility. The principal investigator is a Naval Officer all HIPPA mandates and security 
measures were incorporated to protect the privacy of all medical information obtained for 
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this study. To ensure confidentiality all data was labeled with a unique subject identifier 
that linked the subject with the data, and only the investigators involved in the study had 
access to this link. No personal health information was attached. 
DESCRIPTION OF THE SYSTEM FOR MAINTENANCE OF RECORDS 
Sources of data for this study included the STOP-BANG, Aldrete protocol, and 
Anesthesia Information Management System (AIMS). All instruments were coded using 
each subject's assigned number. The master-coding list was kept in a locked file in an 
assigned office in the anesthesia department at NMCSD and only the investigators 
involved in the study had access to this data. Data was entered into a password-protected 
computer. The only link to the subject's identity was by unique subject identification 
number. No protected health information was on any of the data collection forms or 
computer files. 
Research protocols were maintained in a computer data password protected. 
Completed protocols were stored in compliance with SECNAVINST 3900.39C and 
BUMEDINST 3900.6B. Only the investigators had access to the master list. No 
protected health information was placed on any of the psychometric instruments. These 
measures ensure compliance with HIPAA standards and those of the Clinical 
Investigations Department (CID) at NMCSD. 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 49 
References 
Aldrete, A. J., Kroulik, D. (1970). A postanesthetic recovery score. Anesthesia and Analgesia, 
49(6), 924-934. 
Bamgbade, O., Chung, A.S., Khalaf, W.M., Dwyer, B.J., Alfa, J.A., Tierney, N.M. (2009). 
Survey of perioperative care of adults with obstructive sleep apnoea. European Journal 
of Anesthesiology 26, 706-708. 
Bahammam, A., Delaive, K., Ronald, J., Manfreda, J., Roos, L., Kryger, M.H. (1999). Health 
care utilization in males with obstructive sleep apnea syndrome two years after diagnosis 
and treatments. Sleep, 22, 740-747. 
Benumof, J. L. (2004). Obesity, sleep apnea, the airway and anesthesia. Current Opinion 
in Anesthesiology, 17 21-30. 
Bixler, E. O., Vgontzas, A.N., Lin, H.M., Ten, H.T., Leiby, B.E., Velabueno, A., Kales, 
A. (2000). Association of hypertension and sleep disordered breathing. Archives of 
Internal Medicine, 160, 2289-2295. 
Borel, A. L., Benhamou, P.Y, Baquet, J.P, Halimi, S., Levy, P., Mallion, J.M., Pepin, J.L. 
(2010). High prevalance of obstructive sleep apnoea syndrome in a type 1 diabetic 
adult population: a pilot study. Diabetic Medicine, 27,1328-1329. 
Chasens, E. R., Weaver, T.E., Umlauf, M.G. (2003). Insulin resistance and obstructive 
sleep apnea: is increased sympathetic Stimulation the link Biologic Research for 
Nursing, 5, 87-96. 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 50 
Chung, F., Yegneswaran, B., Liao, P., Chung, S.A., Vairavanathan, S., Islam, 
S., Khajehdehi, A., Shapiro, C.M. (2008). Stop questionnaire: a tool to screen patients for 
obstructive sleep apnea. Anesthesiology, 108, 812-821. 
Chung, S. A., Hongbo, Y., Chung, F. (2008). A Systematic review of obstructive sleep 
apnea and its implications for anesthesiologists. Ambulatory Anesthesiology, 
107(5), 1543-1563. 
Davies, R. J., Ali, N.J., Stradling, J.R. (1992). Neck circumference and other clinical 
features in the diagnosis of the obstructive sleep apnea syndrome. Thorax, 47,101-
105. 
Davies, R. J., Stradling, J.R. (1990). The relationship between neck circumference, 
radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome. 
European Respiratory Journal, 3, 509-514. 
Eastwood, P. R., Malhutra, A., Palmer, L.J., Kezirian, E.J., Horner, R.I., Ip, M.S., 
Thurneer, R., Antic, N.A., Hillman, D.R. (2010). Obstructive Sleep Apnoea: From 
pathogenesis to treatment current controversies and future direction. Respirology, 
15, 587-595. 
Elmarsy, A., Lindberg, E., Berne, C., Janson, C., Gislason, T., Awad Tageldin, M., 
Bowman, G. (2001). Sleep disordered breathing and glucose metabolism in 
hypertensive men: a population study. Journal of Internal Medicine, 249,153-161. 
Gami, A. S., Howerd, D.E., Olsen, E.J., Somers, V.K (2005). Day - night pattern of 
sudden death in obstructive sleep apnea. New England Journal of Medicine, 352, 
1206-1214. 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 51 
He, J., Kryger, M.H., Zorick, F.J., Conway, W., Roth, T. (1988). Mortality and apnea 
index in obstructive sleep apnea. Chest, 94, 9-14. 
Homer, R. I., Mohiaddin, R.H., Lowell, D.J., Shea, S.A., Burman, E.D., Longmore, D.B. 
(1989). Sites and sizes of the fat deposits around the pharynx in obese patients 
with obstructive sleep apnea and wieght matched controls. European Respiratory 
Journal, 2, 613-622. 
Hung, J., Whitford, E.G., Parsons, R.W., Hillman, D.R. (1990). Association of sleep 
apnea with myocardial- infarction. Lancet, 336-, 261-264. 
Ip, M. S., Lam, B., NG, M.M., Lam, W.KTsang, K.W., Lam, K.S. (2002). Obstructive 
sleep apnea is independently associated with insulin resistance American Journal 
of Respiratory Critical Care Medicine, 165, 670-676. 
Kaneko, Y., Floras, J.S., Usui, K. (2003). Cardiovascular effects of continuous positive 
airway pressure in patients with heart failure and obstructive sleep apnea. New 
England Journal of Medicine, 348, 1233-1241. 
Kaw, R., Michota, F., Jaffer, A., Ghamande, S., Auckley, D., Golish, J. (2006). 
Unrecognized sleep apnea in the surgical patient: implications for the perioperative 
setting. Chest, 129, 198-205. 
Kim, J. A., Lee, J.J., Jung, H.H. (2005). Predictive factors of immediate postoperative 
complications after uvulopalatopharyngoplasty. Laryngoscope, 115, 1837-1840. 
Lavie, P., Lavie, L. (2008). Cardiovascular morbidity and mortality in obstructive sleep 
apnea. Current Pharmaceutical Design, 14, 3466 -3473. 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 52 
Leiter, J. C. (1996). Upper airway shape. American Journal of Respiratory Critical Care 
Medicine, 153, 894-898. 
Liao, P., Yegneswaran, B., Vairavanathan, S. (2009). Postoperative complications in 
patients with obstructive sleep apnoea: a retrospective matched cohort study. 
Canadian Journal of Anesthesia, 56, 819-828. 
Mahmood, K., Akhter, N., Eldeirawi, K., Onal, E., Christman, J., Carley, Herdegen, J. 
(2009). Prevalence of type 2 diabetes in patients with obstructive sleep apnea in 
multi ethnic sample. Journal of Clinical Sleep Medicine, 5, 215-221. 
Mansfield, D., Naughton, M. T. (2005). Obstructive sleep apnea, congestive heart failure 
and cardiovascular disease. Heart Lung and Circulation, 145, 52-57. 
Marrone, O., Salvaggio, A., Bonsignore, M.R., Insalaco, G., Bonsignore, G. (2003). 
Blood pressure responsive to obstructive events during sleep after chronic cpap. 
Euoropean Respiratory Journal, 21, 509-514. 
Muraki, I., Tanigawa, T., Yamagishi, K., Sakurai, S., Ohira, T., Imano, H., Kitamura, A., 
Kiyama, M., Sato, S., Shimamoto, T., Konishi, M., Iso, H. (2009). Nocturnal 
intermittent hypoxia and the development of type 2 diabetes: the circulatory risk in 
communities study (circs). Diabetologia, 53,481-488. 
Meoli, A. 1., Rosen, C.L., Kristo, d., Kohrman, M., Gooneratne, N., Aguillard, R.N., 
Fayle, R., Troell, R., Kramer, R., Casey, K.R., Coleman, J. (2003). Upper airway 
management of the adult patient with obstructive sleep apnea in the perioperative 
period-avoiding complications Sleep, 26,1060-1065. 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 53 
Mortimore, I. L., Marshal, I, Wraith, P.K., Seller, R.J., Douglas, N.J. (1998). Neck and 
total body fat deposition in the nonobese and obese patient with sleep apnea 
compared with that in control subjects. American Journal of Respiratory Critical 
Care Medicine, 157,280-283. 
Munro, B. H. (2005). Statistical Methods for Health Care Research (5th ed.): Lippincott, 
Williams & Wilkins. 
Muraki, I., Tanigawa, T., Yamagishi, K., Sakurai, S., Ohira, T., Imano, H., Kitamura, A., 
Kiyama, M., Sato, S., Shimamoto, T., Konishi, M., Iso, H. (2009). Nocturnal 
intermittent hypoxia and the development of type 2 diabetes: the circulatory risk in 
communities study (circs). Diabetologia, 53,481-488. 
Netzer, N. C., Hoegel, J.J., Loube, D., Netzer, C.M., Hay, B., Alverez-Sala, R., Strohl, 
K.P. (2003). Prevalence of symptoms and risk of sleep apnea in primary care. 
Chest, 124, 1406-1414. 
Padelletti, M., Kawat, S.M., Higgens, C., Canfield, S.M., Onat, D. (2008). Inflammation, 
oxidative stress and repair capacity of the vascular endothelium in obstructive 
sleep apnea Circulation, 117, 2270-2278. 
Pamidi, S., Aronsohn, R., Tasali, E. (2010). Obstructive sleep apnea: role in the risk and 
severity of diabetes. Best practice and research clinical endocrinology and 
metabolism. 24, 703-715. 
Pierce, R. J, Worsnop, C.J. (1999). Upper airway function and dysfunction in respiration. 
Clinical Experiments In Pharacology and Physiology, 26, 1-10. 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 54 
Portaluppi, F., Provini, F., Cortelli, P. (1997). Undiagnosed sleep disordered breathing 
among male nondippers with essential hypertension. Journal of Hypertension, 15, 
1227-1233. 
Punjabi, N. M., Beamer, B.A. (2009). Alterations in glucose disposalin sleep disordered 
breathing. American Journal of Respiratory Critical Care Medicine, 179, 235-240. 
Ramachandran, S. K., Josephs, L.A. (2009). A meta-analysis of clinical screening tests for 
obstructive sleep apnea. Anesthesiology, 110,928-939. 
Rashe, Keller, T., Tautz, B., Hader, C., Hergenc, G., Antosiewicz, J., DiGiulio, C., 
Pokorski, M. (2010). Obstructive sleep apnea and type 2 diabetes. European 
Journal of Medical Research, 15, 152-156. 
Ronslosky, P. E., Hemmelgarn, B.R., Heitmen, S.J. (2009). Obstructive sleep apnea is 
associated with diabetes in sleepy subjects.. Thorax, 64, 834-839. 
Ryan, S., McNicholsa, W.T. (2009). Inflammatory cardiovascular risk markers in 
obstructive sleep apnoea syndrome. Cardiovascular and Hematological Agents in 
Medicinal Chemistry, 7, 76-81. 
Seet, E., Chung, F. (2010). Obstructive sleep apnea: preoperative. Anesthesiology Clinics, 
28,199-215. 
Shelton, K. E., Gay, S.B., Hollowell, D.E., Woodsen, H., Suratt, P.M. (1993). Mandible 
enclosure of upper airway and weight in obstructive sleep apnea. American evision 
of Respiratory Disorders, 148, 195-200. 
Stahl, S. M. (2002). Can psychopharmacologic treatments that relieve symptoms also 
prevent disease progression? Journal of Clinical Psychiatry, 63:11, 961-962. 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 55 
Stalford, C. B. (2004). The starling resistor: a model for explaining and treating 
obstructive sleep apnea. American Association of Nurse Anesthesia Journal, 72(2), 
133-138. 
Vanninen, E., Tuunainen, A., Kansanen, M., Uusitupa, M., Lansimies, E. (1996). Cardiac 
sympathovagal balance during sleep apnea episodes. Clinical Physiology, 16,209-
216. 
White, D. P. (1995). Pathophysiology of obstructive sleep apnea. Thorax, 50, 797-804. 
Wilson, K., Stoohs, R.A., Mulrooney, T.F., Johnson, I.J., Guilleminault, C., Huang, Z. 
(1999). The snoring spectrum: acoustic assessment of snoring sound intensity in 
1,139 individuals undergoing polysomnography. Chest, 115, 765-770. 
Woodson, B. T., Garancis, J.C., Toohill, R.J. (1991). Histopathologic changes in snoring 
and OSA syndrome. Laryngoscope, 101,1318-1322. 
Yaggi, H., Mohsenin, V. (2003). Sleep disordered breathing and stroke. Clinical Chest 
Medicine, 24, 223-237. 
Yamauchi, M., Kimura, H. (2008). Oxidative stress in obstructive sleep apnea: putative 
pathways to the cardiovascular complications. Forum Review, 10, 755-768. 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 
TABLES 
Table 1. Pre-Post STOP-BANG & DX OSA 
PRESTOP 
DATA 7.50% 92.50% NS 
POST STOP 
DATA 37.60% 62.40% P< 0.001 
COFACTOR 
DATA 32.60% 67.40% P< 0.001 
Table 2. OSA vs. Non-OSA & Amount Medication 
COFACTOR 2.07 1.53 1.91 
P< 
41 0.05 
MEDICATIONS 1.92 1.13 2.64 
P< 
40 0.01 
TIME 283.76 235.75 1.76 
P< 
40 0.05 
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Table 3. Logistic Regression: Cofactors and effects on OSA 
Variables In the Equation 




Step 1* AirWayProblem 1.884 .638 8.714 1 .003 6.582 1.884 23.001 
HTN 1.017 .528 3.709 1 .054 2.766 .982 7.787 
CAD -.132 .536 .060 1 .806 .877 .307 2.505 
Diabetes -.045 .618 .005 1 .942 .956 .284 3.212 
GERD .201 .469 .183 1 .669 1.222 .488 3.064 
Constant -4.537 1.634 7.708 1 .005 .011 
a. Variable(s) entered on step 1: AirWayProblems, HTN, CAD, Diabetes, GERD. 





t Sig. B Std. Error Beta 
1 (Constant) 475.705 140.381 3.389 .001 
HTN -202.568 48.910 -.453 -4.142 .000 
CAD 56.731 47.692 .125 1.190 .237 
Diabetes 63.708 56.032 .115 1.137 .258 
GERD -15.944 42.381 -.036 -.376 .708 
AirWay Problems -27.213 55.520 -.047 -.490 .625 
a. Dependent Variable: Total PACU Time 
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DIAGRAMS 
FIGURE 1. STARLING RESISTOR MODEL 
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Myocardial Pulmonary Systemic DayTime Sleepiness 
Ischemia HTN HTN j 
1 1 i Accident Prone 
Arrhythmias KVH LVH 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 
APPENDICIES 
Appendix A. Stop Bang Tool 
Appendix B. Aldrete Score 
AppendixC. Datasheet 
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APPENDIX A. 
STOP-Bang Scoring Model 
1. Snoring 
Do you snore loudly (louder than talking or loud enough to be heard through closed 
doors)? Yes No 
2. Tired 
Do you often feel tired, fatigued, or sleepy during daytime? Yes No 
3. Observed 
Has anyone observed you stop breathing during your sleep? Yes No 
4. Blood pressure 
Do you have or are you being treated for high blood pressure? Yes No 
5. BMI BMI more than 35 kg/m2? Yes No 
6. Age Age over 50 yr. old? Yes No 
7. Neck circumference Neck circumference greater than 40 cm? Yes No 
8. Gender Gender male? Yes No 
High risk of OSA: answering yes to two or more items. 
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APPENDIX B. 
Modified Aldrete Scoring 
Activity Able to move four extremities voluntarily on command 2 
Able to move two extremities voluntarily on command 1 
Able to move no extremities voluntarily on command 0 
Respiration Able to breathe deeply and cough freely 2 
Dyspnea or limited breathing 1 
Apneic 0 
Circulation BP ± 20% of pre-anesthetic level 2 
BP± 20 - 49% of pre-anesthetic level 1 
BP ± 50% of pre-anesthetic level 0 
Pulse Rate Pulse ± 20 beats of pre-sedation rate 2 
Pulse± 50 to 21 beats of pre-sedation rate 1 
Pulse>± 51 beats of presedation rate 0 
Consciousness fully awake 2 
Arousable on calling 1 
Not responding 0 
02 Saturation Maintains baseline saturation on room air 2 
Needs 02 to maintain >90% saturation 1 
02 saturation<90% with 02 supplement 0 
• Patients with an Aldrete score of two (2) points or more below baseline must be referred 
to the physician responsible for the procedure for further evaluation. 
• ** Patients equal to baseline post-procedure will be discharged from the procedure area 
as in 5.0 of the Sedation/Analgesia Policy 
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APPENDIX C. 
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Abstract 
Introduction: According to the American Heart Association, fifteen million adults are 
affected by obstructive sleep apnea (OSA).1 Chung et al.5"6 developed, piloted, and 
validated the STOP-BANG questionnaire as an OSA screening tool for surgical patients 
at preoperative clinics. This questionnaire is used to assist the perioperative team with 
routine screening for OSA. The national incidence of sleep apnea is 25% for men and 
10% for women. At Naval Medical Center San Diego (NMCSD) the current incidence of 
sleep apnea is 11%. This study was designed to evaluate the effects of implementing the 
STOP BANG tool in preoperative clinics to identify undiagnosed OSA surgery patients. 
Design and Methods: Pre and post quasi-experimental time series design project to 
include two phases: Phase One: pre-data collection; Phase Two: pre-operative assessment 
form and post-data collection. Five hundred and five charts were reviewed in phase one 
and phase two for a total same size of 1010. Pre and post means were evaluated using a 
student t-test; Chi-Square analyses was used to compare significance of OSA with 
snoring, hypertension, age and BMI. A correlational analysis was utilized to see which 
of the above variables had the most impact on sleep apnea. NMCSD IRB approved. 
Results: There was no difference in demographic data. Pre identification of OSA patients 
was 7.5%. Post identification of OSA patients was 37.6 %. Use of the STOP-BANG 
tool increased OSA detection by 30.1 %. Males and higher ASA classification were 
correlated with OSA (p <0.00). The chance of identifying patients with OSA by using 
the STOP-BANG tool increased by 75% (p<0.001). 
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Conclusions and Implications: Anesthesia and surgery can affect sleep in combination 
with the post-operative effects of anesthesia. Clinical suspicion of OSA may not be clear 
to the anesthesia provider. Use of the STOP-BANG tool in anesthesia pre-screening will 
increase patient safety. 
Keywords: Obstructed Sleep Apnea, obese, STOP-BANG, apnea, hypercapnia, 
hypoxemia, hypertension. 
Introduction 
According to the American Heart Association, fifteen million adults are affected by 
OSA with a higher prevalence in obese men and patients suffering from cardiovascular 
disease.1 OSA is a syndrome characterized by periodic, complete or partial obstruction of 
the pharyngeal airway during sleep.2 Currently, an OSA screening tool is not used in the 
perioperative setting to detect undiagnosed OSA in patients. The current incidence of 
sleep apnea at NMCSD is 11% as indicated by quarterly quality assurance benchmark 
indicators. 
The OSA sufferer has complete cessation of airflow lasting longer than 10 seconds 
during sleep despite continued respiratory efforts resulting in hypercapnia [increased 
carbon dioxide (C02) levels] and hypoxemia.2 Usually the patient's apnea is terminated 
when his or her C02 levels build up enough to stimulate the central nervous system 
(CNS). Stimulation of the CNS arouses the individual enough to overcome the airway 
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obstruction.3 Often the inspiratory effort is a forceful opening of the pharyngeal airway 
and the airway is reestablished by loud snoring.4 Such respiratory efforts may be noted by 
the individual's family as a loud snort or snoring. The apnea causes repetitive arousal 
from sleep to restore airway patency, which may result in a poor sleep pattern with 
daytime sleepiness or hypersomnolence.3 
According to the National Sleep Foundation, one in four Americans are at high risk for 
OSA, making the diagnosis the most prevalent sleep disorder.1 The "Gold Standard" for 
OSA diagnosis is by polysomnography (PSG) to ascertain an apnea-hypopnea index 
(AHI). PSG is conducted during a sleep study.5 The patient wears a sensor attached to 
the head and body to record brain waves, eye movements, muscle activity and 
cardiovascular activity while sleeping overnight in the sleep laboratory. AHI is the 
calculated sum of apneic and hypopnea events experienced during each hour of sleep. 
OSA is diagnosed by the presence of a least five obstructive apneas, hypopneas, or both, 
per hour while the patient is sleeping. OSA is graded into three levels of severity: mild 
(AHI greater than 5 but less than 15 events per hour); moderate (AHI 15 to 30 events per 
hour); and severe (AHI of greater than 30 events per hour).6 PSG requires highly trained 
personnel, complex equipment, and is costly to perform. According to Chung7, most 
sleep study centers have long waiting lists requiring patients to wait for months for OSA 
diagnosis and treatment. Due to patients' inability to have a PSG performed, there has 
been a renewed clinical interest in finding a simple, easy tool to identify undiagnosed 
OSA patients. 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 70 
The American Society of Anesthesiologist published guidelines recommending 
that patients be screened for OSA risk prior to entering the perioperative suite.2 
Typically, surgical patients have their preoperative clinic visit a few weeks prior to 
surgery. OSA has been linked to hypertension, heart failure, atrial fibrillation, stroke, 
myocardial infarction, and nocturnal sudden death.1 Chung7 also suggested that OSA is a 
serious co-morbidity problem and needs to be evaluated for patients with a BMI greater 
than 40. ASA guideline recommendations have produced a number of predictive clinical 
models, but they usually require computer assistance and are not suitable for clinical 
practice.7 As a result, several different questionnaires have been designed for OSA 
screening. These questionnaires are the ASA checklist, Berlin questionnaire, STOP 
questionnaire (snoring, tiredness during daytime, observed apnea, and high blood 
pressure) and STOP-BANG Tool (which includes BMI, age, neck circumference, and 
gender).7 The purpose of this project is to introduce the STOP-BANG tool into our 
preoperative clinic to help identify undiagnosed OSA patients prior to surgery. The 
utilization of the STOP-BANG tool in the pre-operative clinic will aid the perioperative 
team in developing an appropriate anesthesia plan following ASA practice guidelines. 
This should lead to an increase in OSA detection for undiagnosed patients thus increasing 
patient safety. 
Chung et al.5"6 developed, piloted, and validated the STOP-BANG questionnaire 
to be used for surgical patients to assist the anesthesia provider with OSA screening. The 
STOP questionnaire consists of four questions: 
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S: 'Do you snore loudly, louder than talking, or loud enough to be heard through 
closed doors?' 
T: 'Do you feel tired, fatigued or sleepy during the daytime?' 
O: 'Has anyone observed that you stop breathing during your sleep?' 
P: 'Do you have or are you being treated for high blood pressure? 
The questionnaire uses a yes/no format to keep it concise and easy to use.7 If patients 
answer yes to two or more questions, they are at high risk of suffering from OSA. If 
patients have less than two positive answers, they are at low risk of having OSA. The 
STOP questionnaire sensitivity for an AHI of more than 5, more than 15 and more than 
30 events was 65.6%, 74.3%, and 79.3%, respectively.7 
An alternative scoring tool described by Chung et al.5"6 is called the STOP 
questionnaire and BANG-BMI tool. The BANG-BMI portion consists of B - BMI, A -
age, N - neck circumference, and G - gender. The addition of these patient characteristics 
to the STOP questionnaire improves the sensitivity of the tool, detecting most patients 
with OSA; particularly those with severe and moderate OSA.7 In the BANG portion of 
the tool, BMI greater than 35, age older than 50 years, male gender, and neck 
circumference greater than 40 cm are scored positively. Patients answering yes to three or 
more items are considered at high risk for OSA.7 
The BANG addition to the STOP questionnaire increased its sensitivity using an AHI 
greater than 5 (mild), more than 15 (moderate), and more than 30 (severe) events to 
83.6%, 92.9%, and 100%, respectively.7 A moderately high level of sensitivity and 
specificity in surgical patients was demonstrated by the STOP questionnaire, and it was 
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more sensitive for OSA detection in patients with severe (AHI > 30) or moderate (AHI > 
15) OSA. A 100% predictive level could be found with patients with certain clinical 
characteristics: male over 50, BMI greater than 35 and neck circumference greater than 
40 cm.7 Chung et al.5"6 reported that incorporating BMI, age, neck circumference, and 
gender (BANG) into the STOP questionnaire increases tool sensitivity for the 
undiagnosed OSA patient. If the STOP-BANG questionnaire ranks a patient as low risk, 
the patient can be excluded from having moderate to severe OSA.7 
The STOP questionnaire is an easy to use screening tool to identify patients with 
OSA. Incorporating BMI, age, neck size and gender into the STOP questionnaire 
(STOP-BANG) further increases the predictive value for patients with severe to moderate 
OSA. The STOP-BANG questionnaire will aid the perioperative team in evaluating the 
patient for OSA and in developing an appropriate anesthesia plan following ASA practice 
guidelines. The purpose of this study is to see if the STOP-BANG tool can increase the 
identification of patients at risk for OSA, which will decrease their risk for complications 
during anesthesia and improve patient safety. 
Framework 
The Iowa Model of evidence-based practice to promote quality preoperative care gives 
a basic outline to help implement the STOP-BANG tool. The OSA diagnosis is the 
clinical problem to be addressed, but the process of assessment also needs to be improved 
within the clinical setting. Since current research supports utilization of an OSA 
screening tool to identify potential OSA patients, the STOP-BANG tool will aid the 
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anesthesia provider in following ASA practice guidelines for the peri-operative 
management of these patients. 
I n reviewing the literature, there are many case reports of difficult tracheal intubation 
and cardio-respiratory consequences of OSA but very little research on patients with 
OSA and their peri-operative mortality and morbidity.7 In a recent systematic review by 
Chung et al.5"6, the evidence of the potential deleterious effects of anesthesia, sedatives 
and analgesics are compounded for the undiagnosed OSA patient. The increased risk of 
peri-operative adverse occurrences implies that the anesthetic management plan needs to 
be patient specific. It is imperative for the anesthesia provider to meet the challenge of 
maintaining an unobstructed patient airway and preventing perioperative complications.5 
6 The ASA guidelines emphasize the significance of evaluation, detection and 
preparation within the preoperative visit for the OSA patient when going for a surgical 
procedure.2 
Methods / Design 
This study used a pre and post quasi-experimental time series design. One thousand 
and ten patients were enrolled in two phases. Phase One was done before 
implementation of the STOP-BANG tool. Phase Two was completed after 
implementation of the tool. Subjects were recruited in the preoperative clinic. 
Inclusion criteria consisted of the following: 18 years or older, scheduled to undergo 
elective procedures in general surgery, urology, plastic surgery, orthopedics, 
gynecology, ophthalmology and neurosurgery. The subject had to be able to read and 
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write English, alert and oriented. Exclusion criteria consisted of the following: 
subjects who were unwilling or unable to fill out the STOP -BANG questionnaire, 
patients previously diagnosed with OSA or any other sleeping / breathing disorder, or 
patients expected to have abnormal neurological functioning. While filling out their 
anesthesia paperwork, preoperative nurses asked all patients who met inclusion 
criteria to complete the STOP-BANG questionnaire. The STOP-BANG tool is 
displayed in figure 1. 
+ Do you have sleep apnea? 
+ Do you use CPAP at home? 
+ 
+ Scored Questions 
+ 
+ 1. Do you snore loudly? (louder than talking or loud enough to be heard 
+ through closed doors] 
+ 2. Do you often feel tired, fatigued or sleepy during the daytime? 
+ 3. Has anyone observed you stop breathing during your sleep? 
+ 4. Do you have or are you being treated for high blood pressure or 
+ have you been advised to be treated for high blood pressure? 
+ 
+ High risk of OSA: Yes to 2 or more questions 
+ Low risk of OSA: Yes to fewer than 2 questions 
+ 
+ Additional questions: 
2 2 
+ Height cm Weight kg BMIkg/m (35 kg/m ) 
+ Age (50) Gender (M) Neck Circumference cm (40cm) 
+ 
+ Values > those in parentheses increase sensitivity and 
+ decrease specificity of test if included in determining likelihood of OSA 
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Figure 1. STOP-BANG. Adapted from ASA practice guidelines.2 
Every surgery patient was provided a pre-operative packet that included the STOP-
BANG tool. The pre-operative clinic nurse performed the final review of the patient's 
paperwork. The nurse insured that the form was completed and measured the patient's 
neck circumference. Two reviewers performed the baseline data collection before and 
after tool implementation. The patient's characteristics were documented for baseline 
data to assess for the current patient population total. Baseline data consisted of: gender, 
age, weight (BMI), snoring, hypertension, tiredness, and obstruction; if the patient suffers 
from OSA what is the severity; have they had a sleep study; if the patient denies OSA, is 
there a suspicion by the anesthesia provider. 
After implementation of the STOP-BANG tool, statistical analysis was done to 
compare the percentage of pre and post OSA diagnosed patients and to establish a 
baseline for OSA at the facility. Baseline data collected before tool implementation and 
after patients completed the STOP-BANG questionnaire was compared using Chi-square 
to test for differences in gender, age, weight (BMI), snoring, hypertension, tiredness, and 
airway obstruction. The Chi-square test helps determine if the STOP-BANG tool detects 
the undiagnosed OSA sufferer in the elective surgery population. 
To determine the number of undiagnosed OSA patients seen by the pre-operative 
clinic, a pre implementation chart review was performed using the facility's anesthesia 
records. After orientation to the tool for all pre-operative clinic nurses and anesthesia 
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providers, all elective surgery patients were asked to fill out the STOP-BANG 
questionnaire which was placed in a pre-designated position within the chart. 
Data collection related to the incidence of OSA in the population occurred over a three-
month period prior to program implementation and for several months post 
implementation. All post-operative charts were collated within the chart house. The 
charts remained within the chart room for 60 days or until completion by the providers. 
During tool implementation, team members addressed any questions that arose. The 
elective surgery population is a random cluster sample. The sample size was dependent 
on the elective surgery schedule for the month. Chung et al.5"7 and Chung7 articles were 
used to establish the sample size. Five hundred and five patient charts were evaluated in 
the Phase One and Phase Two for a total sample size of one thousand and ten. Ten 
percent was added to the sample size for lost data. The actual number fluctuated 
depending on the rotational basis of surgery residents and deployment schedule of staff 
surgeons. Actual tool performance was simple for patients and pre-operative nurses. Data 
was entered into SPSS 19 to aid in data analysis. Nurses were trained to measure all 
patients for neck circumference uniformly at the level of the cricoid cartilage. 
A regression analyses model was utilized to see which variables impacted the dependent 
variable post implementation sleep apnea. IRB approval was obtained at the primary 
clinical facility and at the university campus. 
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Male 61% 65% NS 
Female 39 35% NS 
Age 47.85 51.50 NS 
BMI 27.32 28.76 NS 
OSA 
diagnosed 
7.5% 37.6% P<0.001 
Hypertension 24% 43% P<0.001 
Snoring 2.6% 30.9% P<0.001 
Medications 1.13 1.92 P<0.01 
PACU Time 235.75 283.77 P<0.05 
Graph 1. Comparison of Positive and Negative Pre-Sleep Apnea Data vs. Post-Sleep 
Apnea Data 
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Pre-Sleep Apnea Data 
Positve 




Table 2. Correlation Analyses Model Results Comparing the Impact of HTN, BMI and 






t Sig. B Std. Error Beta 
1 (Constant) 1.698 .268 6.344 .000 
PoHTN .321 .095 .328 3.391 .001 
PoBMI -.110 .044 -.215 -2.478 .015 
PoAge -.107 .042 -.243 -2.569 .012 
a. Dependent Variable: PoSA 
Results 
This sleep apnea project was completed in two phases. In Phase one, five hundred 
and five post-surgical charts were retrospectively reviewed for demographic and STOP-
BANG data. In Phase Two, five hundred and five surgical patients completed the 
STOP-BANG tool during their preoperative visit, and their charts were retrospectively 
reviewed for demographic and STOP-BANG data. Forty-five charts from each group 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 79 
were dropped due to lost data points. There was no difference in demographic data. Pre 
identification of OSA patients was 7.5%. Post identification of OSA patients was 37.6 
% (Graph One). Use of the STOP-BANG tool increased OSA detection by 30.1% 
(p<0.001). Hypertension, snoring, patient medications and extended PACU times were 
significantly different between the pre and post implementation groups (Table 1). Males 
and higher ASA classification were correlated with OSA (p<0.001). There is a 75% 
increased chance of identifying patients with OSA if the STOP-BANG tool is used 
(p<0.001). A correlation analyses model was completed looking at the impact of 
predictors on post implementation sleep apnea. The correlation model was significant, 
and it appeared that hypertension was the most significant associated with sleep apnea 
(p<0.001). BMI and patient age were also associated with sleep apnea, but not as 
significant (p<0.015, 0.012) (Table Two). 
Discussion, Conclusion and Implications 
Chung et al.5"6 clearly states that the incidence of sleep apnea is 25% for men and 10% 
for women. Before this evidence-based project was undertaken, we were postoperatively 
identifying 11% of sleep apnea patients. During this project, we were able to identify 
37.6% of our surgical population who had sleep apnea. This was a 26.6% improvement 
over our prior clinical assessment. We obtained results similar to Chung et al.5"6 in 
identifying 28.3% of men and 9.3% of women. This project also confirmed Sommers et 
al.1 work that cardiovascular issues such as hypertension may be a predictor for sleep 
apnea as well as snoring and may lead to prolonged recovery time as shown in our work.8 
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Future research is needed to confirm which co-factors impact recovery time in sleep 
apnea patients. In conclusion, anesthesia and surgery can affect sleep apnea in 
combination with the post-operative effects of anesthesia.8 Clinical suspicion of OSA 
may not be clear to the anesthesia provider. The use of the STOP-BANG tool is an easy 
addition to anesthesia pre-screening and increases patient safety. OSA syndrome impacts 
each phase of the anesthesia plan.3 In the pre-operative phase, the nurse or anesthesia 
provider may be the one to assess the patient for OSA prior to surgery. Within the 
operative phase, the anesthesia provider in charge ultimately decides on the type of 
anesthesia and pain medicine the patient is provided during their procedure. Within the 
recovery phase, the patient needs balance in pain control, comfort, and airway patency.3 
The recovery room nurse monitors the patient for depressed ventilatory responses that 
can occur after anesthesia. Typically, hypercarbia and hypoxemia triggers the patient to 
arouse after anesthetics and analgesics, but the OSA sufferer has a depressed response.2 
Using a screening tool can facilitate a diagnosis of OSA, especially for patients who are 
not aware they have it.3 The pre-tool and post-tool evaluation found that 26.6% of 
patients were undiagnosed within our pre-operative clinic. The ultimate long-term goals 
of utilizing the STOP-BANG tool is reducing prolonged recovery room stays by 50% and 
reducing unplanned over-night admissions by 75%. Whether or not this is accomplished 
will be determined in future studies. In a recent by Chung et al.9, patients with OSA were 
found to have an increase in postoperative complications.8 Ultimately, increasing patient 
safety by pre-screening potential OSA patients will decrease our institutional mortality 
rate for undiagnosed patients to zero. The use of a screening tool for OSA will aid the 
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anesthesia provider in the decision-making needed to safely treat these patients intra-
operatively.2 
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ABSTRACT 
Significance/Background: Obstructive Sleep Apnea (OSA) is the most common 
disturbance during sleep affecting 30% of the population. The occurrence of 
moderate/severe OSA is estimated at 11.4% in men and 4.7% in women. OSA is caused 
by repetitive partial or complete obstruction of the upper airway with apnea episodes. 
OSA is prevalent in western society, yet is frequently undiagnosed due to lack of 
knowledge of the disorder. This population presents a challenge during the peri-operative 
period due to increased risk for several complications. Of particular interest to Nurse 
Anesthetists, are respiratory complications that result in delayed emergence from 
anesthesia, delayed post-operative recovery, increased apneic episodes, hypoxemia, and 
death. Examining duration of recovery periods between the two OSA groups will help 
determine if patients with additional cofactors benefit from longer post-operative 
monitoring or modification of anesthetic technique. 
Methods: An observational correlation design to include a non-randomized convenience 
sample of two groups. Comparisons will be made between groups regarding cofactors, 
complications and duration of postoperative recovery times. Patients having elective 
abdominal surgery under general anesthesia at a Military Treatment Facility will be 
identified. OSA status will be determined based upon Sleep Studies, or STOP-BANG 
tool criteria. Medical, surgical, and anesthesia data will be reviewed. Total recovery times 
and pre-existing disease documented. Multiple Logistic and Regression testing will 
compare the effects of cofactors on postoperative recovery times. Chi square analysis will 
evaluate relationship of individual cofactors with OSA and Non-OSA patients. T-test 
analysis will compare demographic information. P score of < .05 will be considered 
significant. 
Results: This study indicated significant correlation with higher number of cofactors 
amongst patients diagnosed with OSA (p< 0.012). Increased incidence of higher ASA 
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classification in OSA diagnosed patients; (p< .017) extended PACU stay time in OSA 
diagnosed patients; (p= 0.05) and Unplanned admissions in OSA patients; (p=. 007). 
Patients with OSA use a higher number of prescribed medications as compared to non-
OS A patients, they have a 3.36 greater chance of having hypertension as an additional 
cofactor (p< .05) and they were 8.75 times more likely to experience airway difficulties 
or complications with general anesthesia when compared to non-OSA patients (p< .05). 
Multiple logistic regression testing demonstrated increased incidence for both airway 
difficulties (p= .003) and Hypertension (p=. 054). Multiple linear regression results 
indicate one cofactor HTN as a significant predictor for PACU stay time. (R2= .179, R2^ 
= .136, F (1)) 
Implications: Findings will lead to optimum monitoring, management; recovery measures 
and anesthesia techniques that will prevent extended postoperative periods and reduce or 
eliminate postoperative complications of OSA. 
Key Words: Obstructive Sleep Apnea, Cofactors, STOP-BANG 
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Introduction 
Obstructive Sleep Apnea (OSA) is the most common disturbance during sleep 
affecting 2-26% of the general population. 12 The occurrence of moderate to severe OSA 
is estimated to be 11.4% in men and 4.7% in women. OSA is a prevalent problem in 
Western Society estimated to occur between 1 to 9% in patients presenting for surgery, 
yet it is frequently undiagnosed due to lack of awareness or knowledge of the disorder.3-4 
OSA is caused by repetitive partial or complete obstruction of the airway during sleep. 
Diagnosis of OSA is determined by the occurrence of airway obstruction during sleep 
with apnea periods lasting greater than 10 seconds for five or more times per hour; with a 
decrease in arterial oxygen saturation (Sa02). These events are known as apnea/hypopnea 
episodes and the measurement of episodes is referred to as the Apnea-Hypopnea Index 
[AHI]. The degree of severity of the disorder is determinate of the number of AHI per 
hour. AHI: 5-15 mild, > 15-30 moderate and > 30 severe.3 4 
A polysomnography otherwise known as a sleep study is recognized as the "Gold 
Standard" for the diagnosis of OSA. Polysomnography data defines the degree of severity 
of the condition and number of apneic episodes. Unfortunately polysomnography is time 
consuming; patients are reluctant to participate in them; they require an extended stay in 
the sleep lab; and they are expensive. Medical professionals have become more aware of 
OSA as a significant disorder with resulting adverse effects for their patients. More 
physicians are consulting to sleep labs to ascertain severity and the availability of 
appointments have become more limited. Unfortunately for the OSA patient, 
polysomnography cannot be obtained rapidly and in the case of surgical interventions that 
may be required for urgent or emergent disorders OSA may go undetected. 12 
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Subsequently, the OSA patient population presents a unique challenge during the peri­
operative period due to an increased risk for lack of identification and subsequent life 
threatening complications. Of particular interest to the Nurse Anesthetist, are the 
respiratory complications that can result in delayed emergence from anesthesia, delayed 
postoperative recovery, increased apneic episodes, hypoxemia, cardiac disturbances and 
ultimate death in this patient population. 
Obesity, gender, snoring and age have demonstrated to be strong indicators of 
occurrence for OSA. Hypertension, cardiovascular disease, diabetes and stroke are 
prevalently reported as confounding and coexisting factors.5 In 2003 Netzer at al, 
surveyed OSA patients in twenty-six US primary care clinics and fourteen European 
primary care clinics comparison of the results demonstrated similar symptoms of age, 
gender distribution and hypertension.6 Obesity was common among both sets of OSA 
patients although the incidence was much higher in the United Sates than in Europe. 
Another study obtained in Spain by Duran et al, 2001 reported linkages between OSA 
and hypertension after interviewing over 2,000 patients.7 Elevated blood pressure and 
refractory bradycardia followed by abrupt tachycardia are cited as predominate 
cardiovascular effects of OSA. The hemodynamic instability seems to be related initially 
to hypoxemia from the airway obstruction, and then sudden arousal as the patient 
awakens to breath. The rapid fluctuation of vaso-activity is thought to be responsible for 
the incidence of cardiac arrhythmias, the development of chronic arterial hypertension, 
the occurrence of myocardial infarction and sudden cardiac death.8 
The severity and incidence of documented post surgical complications from patients 
with moderate to severe OSA is significant. Yet, most of the informational data of 
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incidence, occurrence, surgical complications and treatment of the OSA patients come 
from case reports and retrospective reviews not evidenced based scientific studies. 
The American Society of Anesthesiologist (ASA) developed guidelines in 2006, based 
on Level IV evidence and expert consensus reports to address the identification and 
treatment needs of the OSA patient. The ASA consultants reached agreement on 
treatment criteria for most simple outpatient and minor orthopedic surgical procedures 
but could not find consensus regarding more invasive surgeries. The guidelines propose 
that for more invasive surgery certain factors need to be considered when determining 
postoperative risk for the OSA patient these included: status of sleep apnea, (treated or 
untreated), level of comorbidities (hypertension, cardiovascular disorders, diabetes are 
they appropriately managed), type of surgery, and anesthesia modality.1-2 
Key experts in the diagnosis and treatment of the OSA patient acknowledge poor 
quality of evidence in an article from the American Academy of Sleep Medicine; "the 
scientific literature regarding perioperative risk and best management techniques for OSA 
patients was scanty and of limited quantity".9 
The ultimate goal for all Nurse Anesthetists is to provide the safest, highest quality 
anesthetic management and care to their patients. If Nurse Anesthetists can identify and 
understand the coexisting factors creating the most risks for perioperative complications 
in the OSA defined patient they can better prepare themselves to manage those risks and 
provide optimum care. They can select anesthetic practices that minimize risk and 
maximize safer outcomes. 
Development of more concise and accurate techniques to eliminate the factors 
producing increased risk for this population could be incorporated. Valid criteria for 
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preoperative identification of the OSA patient could be developed and preoperative 
management techniques could be identified. Established guidelines and protocols could 
be created to eliminate most if not all risk factors. The complete elimination of incidence 
and occurrence of morbidity and mortality for the OSA patient in the perioperative 
environment would be the ultimate goal. 
The purpose of this study is to identify the preexisting factors that significantly affect 
postoperative recovery times between patients with Obstructive Sleep Apnea compared to 
patients without Obstructive Sleep Apnea undergoing abdominal surgical procedures. 
Specific aims to determine the incidence and occurrence of pre existing cofactors: 
hypertension, coronary artery disease, and diabetes will be evaluated. Secondary aims 
are to determine if relationships of occurrence exist between the co-existing factors. If 
relationships of co-existing factors are determined can they be further categorized as 
positive or negative relationship? 
OSA will be defined utilizing the STOP-BANG screening parametric, a concise and 
simple to use screening tool specifically developed to assess OSA criteria. Stop-Bang is a 
12-question tool that has been implemented and validated for use in defining OSA 
criteria in a surgical patient population. Obstructive Sleep Apnea is defined by a greater 
than 5 score determined from responses to the 12 question measure. 12 
An English physiologist Ernest Starling identified a theoretical phenomenon of vessel 
capacitance as influenced by flow, forces and pressure. This Theory became known as 
the Starling Resistor Theory and explains the function of fluid flows through the coronary 
arteries. The Starling Resistor Theory is offered as a theoretical framework to compare 
and contrast airway physiology and function within the normal adult airway and in the 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 90 
OSA airway. 
The starling resistor model can be readily applied to describe flow in the upper 
airways. The concept provides an excellent explanation of airway dynamics as influenced 
by changing forces or pressures. A resistor is described as a collapsible tube passing 
through a chamber that is capable of having it's pressure changed. For adaptation 
purposes we can identify the oropharynx as the tube and the surrounding tissue of the 
neck as the chamber. If the oropharynx remains open then airflow through will be 
determined by the pressure differences from the two sides of tissue within the neck; from 
the pressure above; the proximal region of the nose or mouth and from the pressure 
below; the distal portion of the trachea. 
The main characteristic dysfunction of OSA is obstruction of airflow. The patient with 
OSA has recurrent apneic events that are the result of a closed or "blocked" airway that 
occurs during sleep. To understand the co-existing factors that may contribute to the 
adverse affects of OSA we must first understand the anatomic and physiologic process 
that defines OSA. The airway of the OSA patient presents differently than that of a 
typical adult airway. An OSA patient's airway is smaller and narrower in contrast. The 
OSA airway has a more lateral axis while the typical adult airway is more horizontal. An 
excess of redundant tissue causes this variant. In fact a definitive feature of OSA patients 
is an increased neck circumference or "thick neck". When sleeping the oropharyngeal 
muscles of the adult airway are relaxed and pharyngeal narrowing occurs and there is 
increased negative inspiratory pressure especially during rapid eye movement (REM) 
sleep. Additional inspiratory negative pressure is generated by diaphragmatic excursion 
and pharyngeal dilator muscle activity is incorporated as a compensatory mechanism that 
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maintains airway patency in the normal adult. In the OSA patient pharyngeal dilator 
muscle activity maintains patency during awake periods but the muscle activity is lost 
when the OSA patient is asleep. 
Excessive or adipose tissue in the neck of the OSA patient surrounds the oropharynx 
and compresses the airway making muscular activity less effective. Increased negative 
inspiratory pressure along with snoring, which can cause vibratory trauma, can further 
enhance upper airway narrowing. 11 
The tissue pressure (Ptissue) corresponds directly to the pressure with which the 
surrounding tissues of the oropharynx constrict the upper airway. A high opening 
pressure (Pproximal) will assist in overcoming the collapsing pressure of tissue (Ptissue). 
A low or negative pressure below the vocal cords (Pdistal) that occurs as a result of the 
inspiratory effort will contribute to airway collapse if Ptissue is elevated. When 
sufficient muscular tone is operative in tissues surrounding the collapsible tube, in effect 
"lifting the tissue" away from the collapsible portion Ptissue does not contribute to 
airway collapse.12 In the OSA patient arousal is essential for airway patency and 
survival. 
Theoretical Perspective 
Starlings Resistor Theory was formulated to explain the properties of vascular 
compliance and resistance forces. The theory has already been established and accepted 
as defining the properties of fluid flow through blood vessels, and vascular circulation. 
Although the coexisting factors of hypertension and cardiac disturbances in the OSA 
patient are not fully understood an association with flow, increased pressure and 
collapsibility may offer an explanation using Starling's Resistor Theory. Applying this 
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theoretical framework for both airway and hemodynamic pressures is appropriate and 
could indicate symbiotic relationships. 
Fig 1. Starling Resistor Theory Diagram 
Pd (distal)=upstream pressure, Pp (proximal)=downstream pressure and Pt 
(tissue)=pressure in the box.12 
Lack of oxygenation leads to hypoxemia and hypercarbia. Increased levels of C02 
stimulate chemoreceptors within the CNS, which in turn release neurotransmitters 
promoting arousal. Reflex response activates pharyngeal dilator muscles and airways 
open, ventilation is returned. 4 
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The risk of serious postoperative complications has been previously addressed in 
regards to obstructive sleep apnea alone and with coexistence disease. Most OSA patients 
have sleep disorders involving both REM and Non REM sleep. Nocturnal apneic events 
coupled with preoperative anxiety; common prior to surgery, leads to overall poor sleep 
quality, and sleep deprivation prior to surgical events. This causes many patients to 
experience post-operative REM rebound characterized by increased episodes of airway 
atony and subsequently airway collapse. This phenomenon can occur up to the third or 
fourth postoperative day when patients have returned home.13 Benumof 2004, found 
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supporting evidence in the postoperative setting, that sleep mechanics were disturbed due 
to the requirement for increased analgesia for surgical pain. Analgesia through the first 
three days after surgery tended to incur a life threatening apnea from drug-induced sleep. 
He also described rebounds in REM sleep originating from poor quality sleep this was 
believed to increase the danger of a detrimental natural deep sleep- induced apnea. He 
suggested that patients with OSA are at risk of prolonged apnea during sleep for up to 
one week in the postoperative period.14 
Correlations between hypoxic events and episodes of recurrent oxygen desaturations 
associated with adverse outcomes have been reported. Gupta et al (2001) examined 
procedure specific complications in the post operative period and found that OSA 
patients experience significantly more occurrence of complications than the group 
without OSA. Complications included acute hypercapnea, PaCo2 >45, episodic 
desaturations reflected by Sp02 <90% with witnessed apneic events mmHg; arrhythmias, 
MI, or infarction, and delirium.15 
In the United Kingdom a mailed survey was provided to a group of anesthetists to 
define perioperative care of adults with OSA: Perioperative complications included 34% 
difficult intubations, 47% difficult ventilations, 24% cardiovascular instability, difficult 
analgesia in 41%, difficult extubation 13%, postoperative apnea 46%, required 
reintubation 27%, unplanned ICU admission 23%, and acute cardiac events 25%.16 
These findings support the need for accurately assessing the postoperative status of 
OSA patients and determining criteria for risk assessment. Studies have shown strong 
relationships between the numbers of oxygen desaturations episodes within the post 
anesthesia care unit to occurrence of adverse events. 
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Questions could be posed regarding the causes of the postoperative complications. 
OSA attributed events such as: Hypoxia, Hypopnea, Hypercapnea, snoring etc. Are these 
conditions independently caused by the OSA disorder? Or is their synergistic 
components with other cofactors (HTN, Diabetes, CAD) that creates the adverse events? 
Does the OSA patient with one or more cofactors have more adverse events and do they 
require a longer PACU stay? There currently is no clear explanation. It would be valuable 
information for the anesthesia provider and other health care providers to know the most 
significant cause of adverse events in the OSA patient. 
METHODOLOGY 
An observational correlational design method will be utilized for determining the 
relationship of postoperative ambulatory care unit (PACU) stay times and hypertension 
(HTN), diabetes (DM-13), coronary artery disease, and body mass index (BMI) in 
obstructive sleep apnea (OSA) patients. 
Sample 
A purposive sample of active duty, retired, or family members of military service 
members having consented to elective abdominal surgery at the Naval Medical Center 
San Diego (NMCSD) and received a score of 5 or greater from preoperative evaluation 
using the STOP-BANG screening measurement. 
Inclusion Criteria consists of males and females 18 to 65 years, who have elected to have 
general anesthesia for abdominal surgery, category ASA I & II. Exclusion Criteria will 
consist of members above who have pre-existing pulmonary disorders (COPD, etc.), 
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neurological dysfunction, delayed or decreased cognitive function, recent MI. 
Demographic data will include age, gender, BMI, medications and type of surgical 
procedure. 
Sample Size Calculation 
For the purpose of this study which is to determine if identified obstructive sleep apnea 
(OSA) patients have longer PACU recovery times as compared with non-OSA patients 
undergoing abdominal surgery and if their is an association between OSA patients with 
pre-existing factors (HTN, Diabetes, Coronary Artery Disease, BMI) and extended 
PACU recovery times. A multiple logistic regression will be used to analyze the data. 
Several mathematical formulas exist along with computer program power analysis 
software to help determine appropriate sample size. These formulas and software 
programs assure that the number of participants selected for the study provide enough 
information to establish a valid correlation of event and outcome. Published studies have 
cited occurrence of OSA in western populations within the range of 23-38%. '"2'3'14'17 
More specific approximation of incidence of OSA in surgical patients fall within 24-26%. 
1-2 The sample size for this study will be based on the consensus of data establishing a 
26% occurrence rate. Utilizing Nunnally and Bernstein (1994) and Katz (2006) 
guidelines of ten subjects per predictor, 50 subjects with OSA would be a minimum. 
Considering the incidence of OSA in the surgical population of 26% the estimated 
sample size for this study is 119 subjects. 18,19 Data collection for this research will 
consist of a medical record review of patients from the Naval Medical Center San Diego 
who have undergone an elective abdominal surgery utilizing general anesthesia. 
Preoperative, intraoperative and postoperative data will be evaluated for study criteria. 
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Measure of Obstructive Sleep Apnea 
OSA will be defined utilizing the STOP-BANG screening parametric, a concise and 
simple to use screening tool specifically developed to assess OSA criteria. The STOP 
Bang Questionnaire is made up of 4 yes/no questions related to: 
1. Snoring 2. Tiredness 3. Observed Apnea during sleep 4. High Blood Pressure. It is a 
self report, choice (yes/no) paper and pencil scale that takes an estimated 1 minute to 
complete.1 
Aldrete Score Measurement 
Protocols are utilized to immediately assess a patient's recovery from anesthesia after 
surgery. A universally used scale is the Aldrete scale, which scores the patient on 
mobility, respiratory status, circulation, consciousness, and pulse oximetry. The Aldrete 
score was formulated in 1970 and modified in 1992. Aldrete uses a rating scale of 0 thru 
2 to score the five physiological criteria previously listed. A score of 2 in each category is 
considered best in all areas. The patient is discharged from the PACU when they meet 
the established criteria for discharge an overall score of 9. This measurement will be 
utilized to determine overall PACU stay times. 
Results 
Findings from our pilot study of 100 patients demonstrated that OSA patients were 
8.75 times more likely to experience airway difficulties or complications with general 
anesthesia when compared to non-OSA patients (p< .05). We found a significant 
correlation with a higher number of cofactors (co-existing disease) amongst patients 
diagnosed with OSA (p< 0.012) as compared to non-OSA patients. An increased 
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incidence of higher ASA classification (p< 0.017); extended PACU stay time (p< 0.05); 
and unplanned admissions (p<. 007) was also found in OSA patients when compared to 
non-OSA patients. 
In addition patients with OSA had a higher number of prescribed medications as 
compared to non-OSA patients. OSA patients had a 3.36 greater chance of having 
hypertension as an additional cofactor (p< .05) 
Correlation OSA DX YES OSA DX NO SIGNIFICANCE 
PRESTOP DATA 7.50% 92.50% NS 
POST STOP 
DATA 37.60% 62.40% P< 0.001 
COFACTOR 
DATA 32.60% 67.40% P< 0.001 
Table 1. Pre-Post STOP-BANG & DX OSA. 
COFACTOR 2.07 1.53 1.91 41 P< 0.05 
MEDICATIONS 1.92 1.13 2.64 40 P< 0.01 
TIME 283.76 235.75 1.76 40 P< 0.05 
Table 2. OSA vs. Non-OSA amount medications. 
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Multiple logistic regression testing demonstrated increased incidence for both airway 
difficulties (p= .003) and Hypertension (p=. 054). Multiple linear regression results 
indicate one cofactor HTN as a significant predictor for PACU stay time. (R2= .179, R2adj 
= .136, F (1) 
Table 3. Logistic Regression: Cofactors and effects on OSA 
Variables In the Equation 




Step 1a AirWayProbiem 1.884 .638 8.714 1 .003 6.582 1.884 23.001 
HTN 1.017 .528 3.709 1 .054 2.766 .982 7.787 
CAD -.132 .536 .060 1 .806 .877 .307 2.505 
Diabetes -.045 .618 .005 1 .942 .956 .284 3.212 
GERD .201 .469 .183 1 .669 1.222 .488 3.064 
Constant -4.537 1.634 7.708 1 .005 .011 
a. Variable(s) entered on step 1: AirWayProblems, HTN, CAD, Diabetes, GERD. 






Coefficients t Sig. 
B Std. Error Beta 
1 (Constant) 475.705 140.381 3.389 .001 
HTN -202.568 48.910 -.453 -4.142 .000 
CAD 56.731 47.692 .125 1.190 .237 
Diabetes 63.708 56.032 .115 1.137 .258 
GERD -15.944 42.381 -.036 -.376 .708 
Air Way -27.213 55.520 -.047 -.490 .625 
Problems 
a. Dependent Variable: Total PACU Time 
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Discussion 
In Phase I of our study, utilizing the STOP-BANG measurement tool demonstrated 
high predictability in defining OSA in patients with both unknown and suspected OSA 
condition. Complications associated with OSA can be severe and life threatening. These 
complications include: hypoventilation, hypoxia, airway obstruction, intubation 
difficulties, and a higher incidence of myocardial infarction. These complications can 
occur intra-operatively, post operatively and during the PACU stay period. There 
currently exists wide diversity in the postoperative management of the OSA patient. 
There is a consensus that the OSA population requires more stringent anesthesia 
management during induction but even more critical is the post operative period while 
the OSA patient is still under the effects of residual anesthetic agents and narcotics. 
Practice guidelines vary widely within medical facilities in the anesthesia management of 
OSA patients postoperatively. The average PACU stay time for the non -OSA patient is 
under 1 hour. The duration of time that the OSA patient should be observed in the PACU 
is not well defined due to the physiologic changes that occur in the OSA patient airway 
and respiratory mechanics while under anesthesia and sedation. 
The importance of our OSA studies are their validation of instruments that can provide 
valuable preoperative information that would aid identification of surgical patients with 
both known; and more importantly unknown OSA. Phase II study goes further 
identifying the incidence and significance of co-existing factors (cofactors) that influence 
the PACU recovery time of OSA patients as compared with non-OSA patients. Valuable 
information determined from our studies can provide guidelines and protocols 
streamlining and specifying the intraoperative management for the OSA patient in a 
manner that minimizes complications. Significant cofactors can be identified and 
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appropriate optimization measures can be applied. Postoperative measures and protocols 
could be developed to reduce the risk factors and provide for safe analgesia that inhibits 
heavy sedation while promoting optimum oxygenation to eliminate adverse events and 
extended recovery times. 
Limitations 
The obvious limitation in our study was our sample size of 110 subjects. The data for 
our retrospective study was facilitated by the use of an anesthesia information 
management system (AIMS) that was incorporated 18 months prior to this study. 
Although utilization of the AIMS enabled a concise and consistent source of all data 
elements for our study, the number of electronic anesthetic records was not as robust as 
we would have liked. Further studies involving a greater number of records that duplicate 
our results would not only validate our study but may also demonstrate additional 
cofactors influencing OSA. Additionally, we did not incorporate physiologic monitoring 
such as capnography or cerebral oxygen saturation. Physiologic measurements such as 
carbon dioxide (Pco2) and cerebral oxygenation could be incorporated to further 
investigate the synergistic relationship of hypoxia and hypopnea in the OSA patient with 
hypertension, coronary artery disease and diabetes. 
Implications 
By better understanding factors that increase the adverse events of OSA, we can better 
prepare for or even prevent bad outcomes. Identifying characteristics inherently 
consistent in patients with OSA will enable anesthesia to alleviate risks, optimize 
outcomes by implementing supportive measures and anesthesia techniques that will 
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decrease the occurrence of hypoxemia, apnea/hypopnea, hypertensive and cardiac events. 
Preoperative assessment of all surgical patients using validated instruments would 
identify surgical patients with both known OSA and more importantly identify those that 
are unknown. Cofactors can be identified and appropriate optimization measures can be 
applied. 
Future Research 
Once all mitigating factors are better understood anesthesia providers can direct efforts 
for increased study. Additional studies related to the physiological and neurological 
components that affect hypopnea; hypoxia and vaso-activity could provide further insight 
into the obstructive processes that cause the complications in the OSA patient. Optimum 
anesthetic measures and techniques could be investigated and incorporated throughout 
the continuum of perioperative care. Protocols could be developed as guidelines to 
provide safer and consistent quality care. Intraoperative management could be 
streamlined and specified for the OSA patient in a manner that minimizes complications. 
Postoperative measures and protocols could be developed to improve the care for the 
OSA patient; eliminating the risk factors and provide for safe analgesia that inhibits 
heavy sedation while promoting optimum oxygenation and pressure if need be to support 
airways and eliminate adverse events. Patient can be advised regarding self-care 
measures that can enhance their quality of life. Most important for the anesthesia provider 
is the further identification of all contributing and co-existing factors. 
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Introduction 
Obstructive Sleep Apnea (OSA) is the most common disturbance during sleep 
affecting 2-26% of the general population (Chung et. al, 2008). The occurrence of 
moderate to severe OSA is estimated to be 11.4% in men and 4.7% in women (Seet et. al, 
2010) OSA is a prevalent problem in Western Society estimated to occur between 1 to 
9% in patients presenting for surgery, yet it is frequently undiagnosed due to lack of 
awareness or knowledge of the disorder (Kaw et al, 2006). 
OSA is caused by repetitive partial or complete obstruction of the airway during sleep. 
Diagnosis of OSA is determined by the occurrence of airway obstruction during sleep 
with apnea periods lasting greater than 10 seconds for five or more times per hour; with a 
resultant decrease in arterial oxygen saturation (Sa02). (Seet et al, 2010) These events 
are known as apnea/hypopnea episodes and the measurement of episodes is referred to as 
the Apnea-Hypopnea Index [AHI]. The degree of severity of the disorder is determinate 
of the number of AHI per hour. AHI: 5-15 mild, > 15-30 moderate and > 30 severe. 
A Polysomnography otherwise known as a Sleep Study is recognized as the "Gold 
Standard" for the diagnosis of OSA. Polysomnography data defines the degree of severity 
of the condition and number of apneic episodes. Unfortunately polysomnography is time 
consuming; patients are reluctant to participate in them; they require an extended stay in 
the sleep lab; and they are expensive. Medical professionals have become more aware of 
OSA as a significant disorder with resulting adverse effects for their patients. More 
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physicians are consulting to sleep labs to ascertain severity and the availability of 
appointments have become more limited. Unfortunately for the OSA patient, 
polysomnography cannot be obtained rapidly and in the case of surgical interventions that 
may be required for urgent or emergent disorders OSA may go undetected. (Chung, 
2008) Subsequently, the OSA patient population presents a unique challenge during the 
peri-operative period due to an increased risk for lack of identification and subsequent 
life threatening complications. Of particular interest to the Nurse Anesthetist, are the 
respiratory complications that can result in delayed emergence from anesthesia, delayed 
postoperative recovery, increased apneic episodes, hypoxemia, cardiac disturbances and 
ultimate death in this patient population. 
Literature Review 
Obesity, gender, snoring and age have demonstrated to be strong indicators of occurrence 
for OSA. Hypertension, cardiovascular disease, diabetes and stroke are prevalently 
reported as confounding and coexisting factors (Dykes et al, 1996). In 2003 Netzer at 
al, surveyed OSA patients in 26 US primary care clinics and 14 European primary care 
clinics comparison of the results demonstrated similar symptoms of age, gender 
distribution and hypertension. Obesity was common among both sets of OSA patients 
although the incidence was much higher in the United Sates than in Europe. Another 
study obtained in Spain by Duran et al, 2001 reported linkages between OSA and 
hypertension after interviewing over 2,000 patients. 
Elevated blood pressure and refractory bradycardia followed by abrupt tachycardia 
are cited as predominate cardiovascular effects of OSA. The hemodynamic instability 
seems to be related initially to hypoxemia from the airway obstruction, and then sudden 
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arousal as the patient awakens to breath. The rapid fluctuation of vaso-activity is thought 
to be responsible for the incidence of cardiac arrhythmias, the development of chronic 
arterial hypertension, the occurrence of myocardial infarction and sudden cardiac death. 
(Vanninen et al, 1996). 
The severity and incidence of documented post surgical complications from patients 
with moderate to severe OSA is significant. Yet, most of the informational data of 
incidence, occurrence, surgical complications and treatment of the OSA patients come 
from case reports and retrospective reviews not evidenced based scientific studies. A 
retrospective review in 2008 involved a search of surgical procedures involving patient 
who were previously or subsequently diagnosed with OSA. A total of 8,897 articles were 
discovered from 1966 to 2007. Limiting of the search to English language, adult 
population as well as preferentially selected Level I and II categorized studies: 198 
articles were included for analysis whereby the authors clarified further that 18 articles 
were level III and IV (lack of adequate blinding, control group or randomization) due to 
lack of higher level studies. (Chung et al, 2008) 
The American Society of Anesthesiologist (ASA) developed guidelines in 2006, based 
on Level IV evidence and expert consensus reports to address the identification and 
treatment needs of the OSA patient. The ASA consultants reached agreement on 
treatment criteria for most simple outpatient and minor orthopedic surgical procedures 
but could not find consensus regarding more invasive surgeries. The guidelines propose 
that for more invasive surgery certain factors need to be considered when determining 
postoperative risk for the OSA patient these included: status of sleep apnea, (treated or 
untreated), level of comorbidities (hypertension, cardiovascular disorders, diabetes are 
they appropriately managed), type of surgery, and anesthesia modality. (Chung, 2008) 
OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY 110 
The key experts in the diagnosis and treatment of the OSA patient even acknowledge 
poor quality of evidence in a citation from the American Academy of Sleep Medicine 
stating that the scientific literature regarding perioperative risk and best management 
techniques for OSA patients was scanty and of limited quantity. (Meoli et al, 2003) 
Purpose and Specific Aims 
The purpose of this study is to identify the preexisting factors that significantly affect 
postoperative recovery times between patients with Obstructive Sleep Apnea compared to 
patients without Obstructive Sleep Apnea undergoing abdominal surgical procedures. 
Specific aims to determine the incidence and occurrence of pre existing cofactors: 
hypertension, coronary artery disease, and diabetes will be evaluated. Secondary aims 
are to determine if relationships of occurrence exist between the co-existing factors. If 
relationships of co-existing factors are determined can they be further categorized as 
positive or negative relationship? 
Methods 
An experimental correlational design method will be utilized for determining the 
relationship of postoperative ambulatory care unit (PACU) stay times and hypertension 
(HTN), diabetes (DM-II), coronary artery disease, and body mass index (BMI) in 
obstructive sleep apnea (OSA) patients. 
Obstructive Sleep Apnea will be defined utilizing the STOP-BANG screening 
parametric, a concise and simple to use screening tool specifically developed to assess 
OSA criteria. Stop-Bang is a 12-question tool that has been implemented and validated 
for use in defining OSA criteria in a surgical patient population. (Chung, 2008) 
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A purposive sample of active duty, retired, or family members of military service 
members having consented to elective abdominal surgery at the Naval Medical Center 
San Diego (NMCSD) and received a score of 5 or greater from preoperative evaluation 
using the STOP-BANG screening measurement. Inclusion Criteria consists of males and 
females 18 to 65 years, who have elected to have general anesthesia for abdominal 
surgery, category ASA I & II. Exclusion Criteria will consist of members above who 
have pre-existing pulmonary disorders (COPD, etc.), neurological dysfunction, delayed 
or decreased cognitive function, recent MI. Demographic data will include age, gender, 
BMI, medications and type of surgical procedure. 
The sample size for this study will be based on the consensus of data establishing a 
26% occurrence rate. Utilizing Nunnally and Bernstein (1994) and Katz (2006) 
guidelines of ten subjects per predictor, 50 subjects with OSA would be a minimum. 
Considering the incidence of OSA in the surgical population of 26% the estimated 
sample size for this study is — subjects. 
Data Collection Protocol 
1. Patients scheduled for elective surgery are directed to the preoperative clinic to 
complete a preoperative questionnaire. This questionnaire identifies patients having any 
pre-existing disease factors such as hypertension, diabetes, suspected or diagnosed 
obstructive sleep apnea. These patients are flagged and required to have a more in depth 
assessment by an anesthesia provider prior to their surgery, this could occur anytime 
between 1 and 14 days prior to their elected procedure. 
2. After informed consent is obtained demographic data will be obtained and Stop Bang 
Measurement questionnaire collected and a copy maintained in the patient record for the 
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anesthesia providers review on the day of surgery. CPAP use evaluated and instructions 
delivered. 
3. Data reviewed within the patients' medical record will consist of: 
a. Pre-operative Data: The anesthesia pre-operative assessment: (which includes: 
medications, NPO status, surgical procedure, review of prior surgeries, review of 
systems, allergies, pain assessment, tobacco and alcohol use, lab data: the anesthesia 
intraoperative record (innovian computerized electronic record), Essentris PACU 
electronic medical report. 
b. Intra-Operative Data: Information obtained from electronic anesthesia record 
(Innovian) includes all intraoperative anesthetic activity anesthetic agent, pain 
medications, muscle relaxants and use or non-use of relaxant reversal medications, anti­
emetics and patients vital signs throughout the procedure. 
c. Post Operative Data: Aldrete scores, recovery times, respiratory rates, incidence 
of desaturations (02 Sat < 90), pulse oximetry measurements, End tidal C02, Cerebral 
C02, CPAP use, hypertension documentation and treatment. (Benumof, 2004) 
Data analysis plan and procedures. 
V. Timeline: (Illustrate a timeline - including the estimated protocol completion and 
abstract/manuscript submission dates) 
First Article - Manuscript: "Stop Bang Tool use to detect Obstructive Sleep 
Apnea for the anesthesia provider." Submission July 2012 
Second Article - Manuscript "Obstructive Sleep Apnea: and the effects of 
cofactors on PACU Stay Time. Bound and submitted September 2012 
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Third Article - AANA Grant Submission due OCT 1st, submission complete by 
August 1st 2012. 
VI. Budget [List and justify individual items. Be as specific as possible. Equipment 
such as computers will not be funded. The AANA Foundation funds up to 15% indirect 
costs.] 
1. Equipment: Cerebral C02 monitor equipment: 10 Thousand Dollars 
Relevance to Nurse Anesthesia 
The ultimate goal for all Nurse Anesthetists is to provide the safest, highest quality 
anesthetic management and care to their patients. If Nurse Anesthetists can identify and 
understand the coexisting factors creating the most risks for perioperative complications 
in the OSA defined patient they can better prepare themselves to manage those risks and 
provide optimum care. They can select anesthetic practices that minimize risk and 
maximize safer outcomes. 
Development of more concise and accurate techniques to eliminate the factors 
producing increased risk for this population could be incorporated. Valid criteria for 
preoperative identification of the OSA patient could be developed and preoperative 
management techniques could be identified. Established guidelines and protocols could 
be created to eliminate most if not all risk factors. The complete elimination of incidence 
and occurrence of morbidity and mortality for the OSA patient in the perioperative 
environment would be the ultimate goal 
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Implications to Research, Education, Practice, Policy 
By better understanding factors that increase the adverse events of OSA, we can better 
prepare or even prevent bad outcomes. Identifying characteristics inherently consistent in 
patients with OSA will enable anesthesia to alleviate risks, optimize outcomes by 
implementing supportive measures and anesthesia techniques that will decrease the 
occurrence of hypoxemia, apnea/hypopnea, hypertensive and cardiac events. Once all 
mitigating factors are better understood anesthesia providers can direct efforts for 
increased study. Optimum anesthetic measures and techniques could be investigated and 
incorporated throughout the continuum of perioperative care. Protocols could be 
developed as guidelines to provide safer and consistent quality care. Patient can be 
advised regarding self-care measures that can enhance their quality of life. Most 
important for the anesthesia provider is the further identification of contributing and co­
existing factors. The development of accurate and efficient preoperative identification 
measure that could prevent adverse events related to OSA could reduce or eliminate life-
threatening outcomes. 
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TABLES 1. 
Table 1. Pre-Post STOP-BANG & DX OSA 
Correlation OSA DX YES OSA DX NO SIGNIFICANCE 
PRESTOP 
DATA 7.50% 92.50% NS 
POST STOP 
DATA 37.60% 62.40% P< 0.001 
COFACTOR 
DATA 32.60% 67.40% P< 0.001 
Table 2. OSA vs. Non-OSA & Amount Medications. 
COFACTOR 2.07 1.53 1.91 41 
P< 
0.05 
MEDICATIONS 1.92 1.13 2.64 40 
P< 
0.01 
TIME 283.76 235.75 1.76 40 
p< 
0.05 
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TABLES 2. 
Table 3. Logistic Regression: Cofactors and Effects on OSA 
Variables In the Equation 




Step 1" AirWayProblem 1.884 .638 8.714 1 .003 6.582 1.884 23.001 
HTN 1.017 .528 3.709 1 .054 2.766 .982 7.787 
CAD -.132 .536 .060 1 .806 .877 .307 2.505 
Diabetes -.045 .618 .005 1 .942 .956 .284 3.212 
GERD .201 .469 .183 1 .669 1.222 .488 3.064 
Constant -4.537 1.634 7.708 1 .005 .011 
a. Variable(s) entered on step 1: AirWayProblems, HTN, CAD, Diabetes, GERD. 





t Sig. B Std. Error Beta 
1 (Constant) 475.705 140.381 3.389 .001 
HTN -202.568 48.910 -.453 -4.142 .000 
CAD 56.731 47.692 .125 1.190 .237 
Diabetes 63.708 56.032 .115 1.137 .258 














a. Dependent Variable: Total PACU Time 
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